A study on prevalence of voiding and defecatory dysfunction in postmenopausal women with pelvic organ prolapse by Nanthini, V
 
 
 
A STUDY ON PREVALENCE OF VOIDING AND DEFECATORY 
DYSFUNCTION IN POSTMENOPAUSAL WOMEN WITH 
PELVIC ORGAN PROLAPSE 
 
 
 
 
 
 
 
                                                
 
 
 
 
 
 
 
A dissertation submitted to Tamil Nadu DR. M.G.R. Medical University, 
Chennai, in partial fulfillment of the rules and regulations for the degree 
M.S. (Branch II) in Obstetrics and Gynaecology, to be held in April 2017. 
 
 
 
 
 
 
 
DECLARATION 
 
I hereby declare that this dissertation titled “A study on prevalence of 
voiding and defecatory dysfunction in postmenopausal women with pelvic 
organ prolapse” is carried out by me under the guidance and supervision of 
Dr.Aruna Nitin Kekre, Professor of Obstetrics and Gynaecology Unit-II, 
Christian Medical College, Vellore. This dissertation is submitted in partial 
fulfillment of the requirements for the degree of M.S in Obstetrics and 
Gynaecology examination of the Tamil Nadu Dr.M.G.R.Medical University to 
be held in April 2017.  
 
 
Vellore         Dr. Nanthini. V  
Date:  
 
 
 
 
 
 
 
 
 
CERTIFICATE 
 
This is to certify that the “A study on prevalence of voiding and 
defecatory dysfunction in postmenopausal women with pelvic organ 
prolapse” is a bonafide work of Dr. Nanthini.V that was carried out under my 
guidance and supervision for the M.S. (Obstetrics and Gynaecology) 
examination of the Tamil Nadu DR.M.G.R. Medical university, to be held in 
April 2017. 
 
 
 
 
Dr. Aruna Nitin Kekre 
Professor of Obstetrics and Gynaecology –Unit II 
Christian Medical College & Hospital, Vellore-632004. 
Tamil Nadu. 
 
 
 
 
 
 
 
CERTIFICATE 
 
This is to certify that the dissertation “A study on prevalence of voiding 
and defecatory dysfunction in postmenopausal women with pelvic organ 
prolapse” is a bonafide work of Dr. Nanthini.V that was carried out under my 
guidance and supervision for the M.S. (Obstetrics and Gynaecology) 
examination of the Tamil Nadu DR.M.G.R. Medical university, to be held in 
April 2017. 
 
Dr. Annie Regi 
Professor and Head  
Department of Obstetrics and Gynaecology  
Christian Medical College & Hospital, Vellore-632004. 
Tamil Nadu. 
 
 
 
The Principal 
Christian Medical College & Hospital  
Vellore-632004, Tamil Nadu. 
 
 
ACKNOWLEDGEMENTS 
I would like to express my sincere gratitude to Dr.Aruna Nitin Kekre, Professor of 
Obstetrics and Gynaecology- Unit-II, Christian Medical College and Hospital, for her 
valuable help, guidance and support in this endeavor. I am especially grateful to her for 
introducing me to this subspecialty of urogynaecology and motivating me to do this work on 
postmenopausal women with pelvic organ prolapse. 
I am grateful to Dr. Lilly Varghese, Professor and Head of Obstetrics and 
Gynaecology- Unit II, Dr. Vaibhav Londhe, Associate Professor of Obstetrics and 
Gynaecology- Unit II, for their co-guidance. I am indebted to Dr. Nitin Kekre, Professor and 
Head of Unit -II, Urology Department, Christian Medical College, Vellore, for his valuable 
guidance and support. 
I would like to acknowledge Dr. Thambu David, Professor and Head of Medicine -
Unit II for creating interest in research and Dr. Vishalakshi, Department of Bio-statistics, for 
her valuable help in statistical analysis of data. I am thankful to the institute research 
committee for their suggestions and financial support. 
My heartfelt gratitude to Mr. Madhan, from department of CEU, Mrs. Manimozhi and 
Mr. Samuel Jebaraj from Obstetrics and Gynaecology Unit II for their help and assistance. I 
am thankful to my patients for their willingness and co-operation, without whom this study 
would not be possible. I thank my husband Dr. N. Saravanan and my daughter S. Lithika and 
my parents for their support and encouragement for doing this work. 
Above all I thank God for being my strength to do this research work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONTENTS 
 
1. INTRODUCTION       1 
2. AIMS AND OBJECTIVES       3 
3. REVIEW OF LITERATURE          4 
4. MATERIALS AND METHODS      45 
5. RESULTS       59 
6. DISCUSSION       71 
7. CONCLUSION       76 
8. BIBLIOGRAPHY       77 
9. ANNEXURES       83
1 
 
Introduction 
 International continence society  defined pelvic organ prolapse “as the the symptomatic 
descent of the anterior vaginal wall, the posterior vaginal wall, the apex of the vagina or the 
vaginal vault” [1]. Women with POP may presents with symptoms of urinary incontinence, 
fecal incontinence, voiding dysfunction, and defecatory dysfunction, this interrelated group 
of conditions collectively describe as “Disorders of the Pelvic Floor” [2]. POP  usually have 
multifactorial risk factors often harmonize with  each other leads to severe illness .The 
symptoms of POP can impact her  day to day life ,sexual function, adversely have emotional 
impact  [3]. 
 Management of Pelvic organ prolapse involves significant healthcare resources; In 
United States about 300 million dollars are spent on  the health  care of women with POP 
during 2005  [4] The “surgical repair of prolapse”   was the common surgery performed in  
elderly women during  the period of 1979 to 2006 [5]. As age advances POP increased  and 
result in negative impact on health care [6]. Women with symptomatic POP may present with 
a single symptom such as vaginal bulge, pelvic pressure, urinary, bowel and sexual 
symptoms.  
Understanding of the symptoms attributed to prolapse allows one to counsel patients 
appropriately about the surgical repair. Until recently, the association between specific 
symptoms and severity of prolapse was largely unknown [7]. 
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 In recent years, several studies have attempted to fill this void. The present study aims to 
understand the prevalence of voiding  and defecatory dysfunction in postmenopausal women 
with pelvic organ prolapse and to correlate with stage and compartment of prolapse. The 
available outcome of these measures can be used by clinicians and researchers to assess the 
functional outcomes of prolapse and its treatment on patients with an emphasis on symptom 
and QOL assessment. 
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Aims and Objectives of the Study: 
Aims: 
 To study the prevalence of voiding and defecatory dysfunction in  
post- menopausal women with pelvic organ prolapse. 
Objectives: 
Primary objective 
 To correlate the stage  and compartment of prolapse with voiding 
dysfunction using maximal flow rate( Q max) and post void residual urine 
volume( PVR) and defecatory dysfunction using CRADI- 8 (colorectal 
distress inventory-8) bowel subscale score with in PFDI-20 (short form of the 
pelvic floor distress inventory). 
 To correlate stage of pelvic organ prolapse(POP) with Lower urinary tract 
symptoms(LUTS) using International prostate symptom score (IPSS) 
 To correlate the stage of POP with quality of life (QOL) using International 
prostate symptom score (IPSS). 
 
 Secondary objective 
 To correlate stage of prolapse with the preoperative and postoperative 
maximal flow rate (Qmax) and post void residual urine volume (PVR). 
 To correlate the pre and  postoperative voiding dysfunction  
 To correlate pelvic organ prolapse quantification (POP-Q) points with 
voiding and defecatory dysfunction. 
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Review of Literature 
Incidence 
The longevity of life is increasing in India. Aged population more than 60 years has 
grown from 6% in 1950 to 8% in 2000 and is expected  to be 13% in next 10 yrs [8,9]. About 
30% of women attending gynecology OPD and 50% of women over 50 years have POP [10]. 
According to a study done by Oslen et al, there is  11% life time risk for surgical procedure 
due to  pelvic organ prolapse  and 30% will require repeat surgery [11].  
 
The WHO assessments   showed 33 % of the total global burden of disease is related 
to women health [12,13].  POP world wide prevalence is 2 to 20 %   less than 45 years of age 
[14]. In India women suffer from  POP is about ,1 million  and more  in reproductive age 
group[15]. The POP present in 50% of women and only 20%   taken treatment. [16]. 
 
In this hospital CMC& H(Tertiary care hospital located in Vellore, SouthIndia). 
Every month more than 500 patients attending Gynaecology Outpatient department and 
about 150 surgeries are done for gynecological   Problems per month and nearly 10 surgeries 
are done for Uro-gynecological  issues. 
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History: 
Pelvic organ prolapse (POP) was first described in medical history  by  “Ebers 
Papyrus in 1500 B.C”. pelvic organ prolapse remains a common and devastating female 
pelvic floor disorder, with significant effect on quality of life. Recommendations “to repair 
the displaced womb" were described in the Ebers Papyrus. Hippocrates described 
pomegranate pessaries to reduce POP. Succussion (tying a woman upside down by her feet 
until the prolapse reduced) was  described in history. Leonardo Da Vinci (1452-1519) 
contributed to texts after extensive cadaveric pelvic dissection. Andrea Vesalius enlightened 
the entire female genital tract and uterine ligaments. By the end of the 16th century, pessaries 
were being widely used, evolving from lint balls to those made of brass, cork, wood or metal, 
then rubber in 1844.  
During the latter half of the 19th century dramatic advances occurred in surgical 
instruments. James Sims propagated the use of silver sutures in pelvic repair surgery in 1852. 
The first vaginal hysterectomy surgery  for POP was reported by Choppin, of New Orleans, 
in 1861. Alwin Mackendrot described the pelvic connective tissue ,cardinal ligaments in 
1895. Archibald Donald and William Fothergill established the Manchester operation to 
counter POP. Le Fort developed partial colpocleisis in 1877, a technique still used today. In 
1898, Thomas Watkins, not believing in removal of the  uterus ,with out any disease,  and 
described interposition surgery. In 1971 two American gynecologists, Randall and Nichols 
reported  the surgical outcomes of transvaginal sacrospinous fixation in women with vault 
prolapse. Two major changes have occurred in POP surgery: introduction of vaginal mesh 
and advanced endoscopic surgery. Graft use in pelvic reconstructive surgery can be 
tracedback to the early 1900s. Over the  years, a number of autograft, allograftandxenografts  
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ANATOMY OF PELVIC SUPPORT —The muscles, connective tissue  of pelvic floor and 
and its attachment  bony pelvis gives anatomic support to pelvic organ (fig 1) 
  
  
 
 
  
                
 
 
Figure 1. Superior view of female pelvis 
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The levator ani muscle complex, contains pubococcygeus, puborectalis and iliococcygeus 
muscles, which gives primary support to the pelvic organs. (Figure 3 and Figure 4). 
 
 
Figure 2. Muscles of the anterior pelvis and pelvic floor. 
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Figure 3. Pelvic diaphragm - view into the pelvic floor illustrating the muscles of the pelvic 
diaphragm and their attachments to the bony pelvis. 
The endopelvic fascial attachments, referred to as the uterosacral and cardinal 
ligaments, steady the pelvic organs in the correct position so that the pelvic muscles can 
provide optimal support (Figure 5) [18]. 
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Figure 4. (A)  Pelvic girdle Joints  girdle. (B and C) The ligaments of the pelvis are shown.  
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Levels of pelvic organ support — The  levels of vaginal support was described by De 
Lancey [19,20]. The endopelvic fascia connects  levels of support . 
 
 
 
 
 
 
 
 
Figure 5. DeLancey levels of vaginal support. 
 
 
●Level 1 –   complex of Uterosacral/cardinal ligament  supports   the uterus and upper vagina  
this  support represents vertical fibers of the paracolpium that are a continuation of the 
uterosacral/cardinal ligament complex which inserts variably into the cervix and vagina 
(Figure 6) [21]. 
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  In a magnetic resonance imaging (MRI) study of asymptomatic women, the uterosacral 
ligaments were found to originate on the cervix in 33 percent, cervix and vagina in 63 
percent, and vagina alone in 4 percent [22]. Loss of level 1 support contributes to the 
prolapse of the uterus and/or vaginal apex. 
●Level 2 – Paravaginal attachments along the length of the vagina to the superior fascia of 
the levator ani muscle and the arcus tendineus fascia pelvis (also referred to as the “white 
line”). Loss of level 2 support contributes to anterior vaginal wall prolapse (cystocele). 
●Level 3 – Perineal body, perineal membrane, and superficial and deep perineal muscles, 
which support the distal one third of the vagina. Anteriorly, loss of level 3 support can result 
in urethral hypermobility. Posteriorly, loss of level 3 support can result in a distal rectocele or 
perineal descent. 
Nerve supply — The innervation of the pelvic region derives from the S2, S3, and S4 
segments of the spinal cord, which fuse to form the pudendal nerve. The pudendal nerve 
innervates the external anal sphincter, whereas the levators, coccygeus muscles, and 
urogenital diaphragm appear to be innervated by a direct connection of S2, S3, and S4 nerve 
fibers [23]. 
Pelvic floor dysfunction  
Refers to a wide range of  symptoms that occur when muscles of the pelvic floor are weak, 
tight, or impairment of the sacroiliac joint, lower back, coccyx, or hip joints. Symptoms  can 
range from  pelvic pain, pressure, dyspareunia, incontinence, incomplete emptying, and gross 
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organ protrusion [24]. Tissues adjoining the pelvic organs may have increased or decreased 
sensitivity or irritation resulting in pelvic pain. Pelvic floor dysfunction may comprise  group 
of clinical conditions that includes urinary incontinence, fecal incontinence, pelvic organ 
prolapse, voiding dysfunction due to motor and sensory abnormalities of the lower urinary 
tract, defecatory dysfunction, sexual dysfunction and several chronic pain syndromes, 
including vulvodynia. The three most definable conditions faced clinically are urinary 
incontinence, anal incontinence and pelvic organ prolapse [25]. 
RISK FACTORS  
The pelvic organ prolapse has multifactorial etiology and results from a combination of risk 
factors, which vary from patient to patient.  Established risk factors for POP include parity, 
advancing age, and obesity [26,27]. To understand the etiology of prolapse is to prevent and 
treat the problem in early stage. 
The site-specific defect theory is based on the  fact that tears in the ‘‘endopelvic 
fascia” surrounding the vaginal wall permit  herniation of the pelvic organs. The vaginal wall 
is composed   of squamous epithelium, smooth muscle   muscularis, and adventitia. All 
elements are embedded in an extracellular matrix that includes collagen and elastin fibers and 
smooth muscle. Abnormalities of any of these components may contribute to vaginal 
dysfunction and the development of pelvic organ prolapse. 
 
 
 Vaginal delivery is  the greatest risk factor for pelvic organ prolapse, due to neuromuscular 
injury that  leads to pelvic organ prolapse . Snooks performed a studies  to document the 
injuries to  perineal nerve in  parous women. [25] Morphologic changes in the levator 
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muscles of women with prolapse can be documented by pelvic magnetic resonance imaging 
as well as on muscle biopsy [11,12 ]. 
A r study by DeLancey documented injury to the levator ani muscles in vaginally parous 
women.[11,12].The evidence for neuromuscular injury contributing to pelvic organ prolapse 
is  playing  an important role in the development of prolapse in  women. 
Parity: The risk of POP increases with increasing parity [28,29]. The Oxford Family 
Planning study, a prospective cohort study of more than 17,000 women followed for 17 years 
found that, compared with nulliparity, the risk of hospital admission for POP increased 
markedly after the first (4-fold) and second birth (8-fold), and then increased less rapidly for 
subsequent births (third: 9-fold; fourth: 10-fold) [29]. Among parous women, it has been 
estimated that 75 percent of prolapse can be attributed to pregnancy and childbirth [30]. 
Obstetric factors in addition to parity can influence the risk of prolapse. POP can 
develop during pregnancy prior to delivery. Vaginal delivery is associated with a higher 
incidence of POP than cesarean. In the Pelvic Organ Support Study (POSST), increasing 
parity was associated  with advancing prolapse[29]. 
 
Age: The  POP   more in Older women [31]. 100% increased risk of prolapse for each decade 
of life  by POSST  [29]. Olsen  showed   the total  incidence of primary operations for 
prolapse and incontinence increased from 0.1%  at  20- to 29-age group to 11.1%  in 70- to 
79-age group.  
Aging is a complex process and the increased incidence of  prolapse may be the result 
of the combination of physiological aging,  hypoestrogenism,  and an increased incidence of 
age-related degenerative and organic diseases.  
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Women who develop prolapse at early age  have a more severe form of the disease 
than older women[31]. Women  with spina bifida and weak  pelvic floor muscles may  
present at a young age with advanced pelvic organ prolapse. 
A progressive increase in the rate of prolapse with age was reported in one study 
among 1000 women presenting for an annual gynecological exam; every additional 10 years 
of age conferred an increased risk of prolapse of 40 percent [32]. In contrast, in the NHANES 
study described above, the proportion of women with symptomatic prolapse was lowest in 
young women and then remained fairly constant over age 40 years: ages 20 to 39 (1.6 
percent); 40 to 59 (3.8 percent); 60 to 79 (3.0 percent); and ≥80 (4.1 percent). women likely 
to  have a neuromuscular etiology for their prolapse. 
 
Obesity: Overweight and obese women (body mass index >25) have a two-fold higher risk 
of having prolapse than other women [32]. While weight gain is a risk factor for developing 
prolapse .However, it is controversial whether weight loss results in prolapse regression. A 
study of 16,608 postmenopausal women found no association with weight loss and 
regression of POP [33]. However, there are reports of POP regression in women after 
bariatric surgery [34]. 
 Numerous studies have identified obesity as an independent risk factor for stress 
urinary incontinence. [34].However, the association between obesity and the development of 
pelvic organ prolapse is less clear. In some studies, increased body mass index has been 
associated with pelvic organ prolapse 3; however, other studies have failed to find a 
correlation between prolapse and  increased body mass index. 
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Menopause: Genitourinary structures are rich in estrogen receptors. The female genital and 
lower urinary tracts share a common embryological origin arising from the urogenital sinus. 
And both the systems respond to the female sex steroid hormones [35]. The effect of 
endogenous estrogen on the urogenital tissue is mediated through ER Alpha & Beta, 
Progesterone & Androgen receptors [36].  
 
Fig.6. Diagram of development of urogenital sinus. 
The anatomical and physiological changes occur in the Perimenopausal and 
immediate postmenopausal period. And hence Estrogen deficiency in postmenopausal affects 
the urogenital organs and leads to genitourinary syndrome 
Estrogen affects the continence mechanism by increasing the urethral pressure.  
Estrogen receptors are present  in the the proximal and distal urethra  and   improve the 
maturation index. Estrogen causes increase blood flow to the urethra and sphincter and 
Increases the mucosal cooptation [35-37]. 
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It increases the urethral closure pressure and improves pressure transmission to proximal 
urethra an action that promotes continence. In postmenopausal women with estrogen 
deficiency a positive urethral pressure cannot be maintained and with increased Intra-
abdominal pressure there is leakage of urine   result in  Stress urinary incontenance(SUI)[37]. 
Histology of urethra 
 
 
 
 
 
 
 
 
Figure 7.Histology of urethra  
During the menopausal transition, voiding symptoms, like frequency, Urgency, incontinence 
can potentially worsen in the perimenopausal period, and SUI is more common in the 
postmenopausal women and this study had showed, testosterone may have a role in voiding 
changes that occur during the menopausal transition. 
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Estrogen and bladder function 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.Neural control of bladder.  
Sex hormone influences central neurological control of micturition.Estrogen receptors  
are present in the  cerebral cortex, limbic system hippocampus and cerebellum. 
 
Estrogen increases the Sensory threshold of bladder, enhance the  Alpha Adreno 
receptor sensitivity in  the urethral smooth muscles  and causes  Beta -3 Adreno receptor  
mediated  relaxation of the bladder. Thus  Reduces the  rhythmic Detrusor contractions . 
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Figure 9.  Distribution of cholinergic and adrenergic receptors in bladder 
Estrogen receptors  are present in  the dome of the bladder, trigone that undergo squamous 
metaplasia. Estrogen directly affects detrusor functions through modification in the 
muscarinic receptors  and reduces the involuntary detrusor contraction[37]. Withdrawal of 
estrogen in post menopausal women is a common cause for voiding dysfunction. 
 
Effect of estrogen on periurethral tissues 
Genital tract Connective tissue consists mainly of collagen and structural glycoprotein and is 
considered as an important factor responsible to support the pelvic organs. Estrogen 
influences collagen tissue synthesis and directly affects collagen metabolism in lower genital 
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tract. Estrogen is  essential  to maintain  the tensile strength and elasticity of the connective 
tissue in order to support the genital organs and urethra[36]. 
 
Lack of estrogen decreases the volume of the vaginal muscles, resulting in weakness of the 
ligaments holding the uteric pelvic floor and the bladder, resulting in the development of 
prolapse of the internal genitalia leading to Pelvic organ prolapse and stress urinary 
incontinence[37]. 
. 
Hysterectomy: The incidence of clinically significant post-hysterectomy vaginal vault 
prolapse requiring surgical intervention has been estimated at 36 per 10,000 person years . 
Marchionni et al, showed  the total incidence of post-hysterectomy vault prolapse as 1.8%, 
but may increase to 11.6% in women who had hysterectomy for  Pelvic organ prolapse. [38]. 
This indicates that postoperative vault prolapse is likely to result from preexisting poor 
function of supporting structures. 
The uterine cervix and the vagina are stabilized by the endopelvic  fascia and its 
extensions, the cardinal and uterosacral ligaments.  As already mentioned  above the vaginal 
axis is directed  horizontally and is supported by the levator plate.  vaginal birth  cause 
damage to these supporting structures and  leads to a change in the vaginal axis and descent 
of the pelvic organs through the levator hiatus. These events  result in pelvic organ prolapse.  
Hysterectomy is associated with an increased risk of apical prolapse. Factors that may 
influence the risk of prolapse after hysterectomy are age and the surgical route (abdominal or 
vaginal). The  prolapse surgery is  aimed  to improve the patient’s overall quality of life, 
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careful consideration of the benefits and limitations of surgery must be undertaken before 
intervention. The patient’s age, life expectancy, future strain acting on the pelvic floor, coital 
function and co morbid  medical conditions should be the part of preoperative evaluation. 
The patient’s perception of her  symptoms  will be influenced by her understanding of 
the benign nature of  pelvic organ prolapse, the  effect  on quality of life, and the probability 
that the symptoms troubling her will improve after surgery[39].. 
Race and ethnicity: Data suggest that African-American women have a lower 
prevalence of symptomatic POP than other racial or ethnic groups in the US [40]. In a 
prospective cohort study of 2270 women, the risk in Latina and white women was four- to 
five-fold higher than in African-American women [40]. In contrast, other studies have found 
no relationship between POP and race or ethnicity [41]. 
Other risk factors: Chronic constipation , results in repetitive increases in intraabdominal 
pressure [42,43]. Data conflict regarding whether the risk of prolapse is increased in women 
with occupations that involve heavy lifting [43]. Some connective tissue disorders (eg, 
Ehlers-Danlos syndrome) or congenital anomalies of the  bladder econtribute to POP [44].  
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Symptoms associated with pelvic organ prolapse 
 
 
 
Bulge symptoms  
 
Bulge or herniation symptoms that have been attributed to worsening pelvic organ 
prolapse include a sensation of bulging or protrusion in the vagina, a sensation of 
‘‘something falling out’’ of the vagina, actually seeing or feeling a vaginal or perineal 
Bulge Symptoms 
 
Sensation of vaginal bulging or protrusion  
Seeing or feeling a vaginal or perineal 
bulge  
Pelvic or vaginal pressure 
Heaviness in pelvis or vagina 
Urinary Symptoms 
 
Urinary incontinence  
Urinary frequency Urinary urgency  
Weak or prolonged urinary stream  
Hesitancy  
Feeling of incomplete emptying  
Manual reduction of prolapse to start or 
complete voiding 
Position change to start or complete 
voiding 
 
Bowel Symptoms 
Incontinence of flatus or liquid/solid stool  
Feeling of incomplete emptying 
Hard straining to defecate  
Urgency to defecate  
Digital evacuation to complete defecation  
Splinting vagina or perineum to start or complete 
defecation 
Pelvic floor dyssynergia 
Feeling of blockage or obstruction during defecation 
Sexual Symptoms 
Dyspareunia  
Decreased lubrication  
Decreased sensation  
Decreased arousal or orgasm 
 
Pain 
Pain in vagina, bladder, or rectum  
Pelvic pain  
Low back pain 
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bulge, as well as pelvic pressure, fullness, and heaviness. Samuelsson et. al. evaluated pelvic 
organ support in 487 women presenting for a regular gynecologic health examination . Some 
degree of prolapse was noted in 30.8% of subjects, with only 2% having prolapse that 
reached the introitus.  A sense of heaviness in the lower abdomen was noted in 9.7% 
of women with some degree of vaginal prolapse compared with 7.5% in the group with 
normal vaginal support, a non-significant difference. [45]. 
 
Urinary  symptoms  
Urinary bladder and urethra are well supported by anterior vaginal wall. loss of this 
support results in  cystocele formation, which  cause  stress urinary incontinence. It is 
therefore pelvic organ prolapse and stress urinary incontinence often coexist. Urinary 
symptoms can be grouped under three category as follows, 
Abnormal storage Abnormal voiding Abnormal sensation 
Incontenance: urge,stress 
Frequency /nocturia 
Nocturnal enuresis 
Staining to void 
Hesitancy  
Incomplete emptying 
Poor stream 
Post micturition dribble 
Urgency 
Dysuria 
Absent sensation 
Painful bladder 
Urinary symptoms are not always attributed to the prolapse. But some of the 
symptoms in prolapse may be due to urethral kinking which includes urinary hesitancy,poor 
stream of voiding,Incomplete voiding,  Need  to reduce the vaginal bulge manually to 
void(splinting),Need to push on the lower abdomen to void(crede maneuver),positional 
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changes made to void,post void urinary dribble,urinary urgency,frequency,incontenance and 
urinary retension. 
Urinary incontinence: This is defined as the complaints of any involuntary loss of urine. 
Urge and urge urinary incontinence: “compelling sudden desire to pass urine” . 
 Urge urinary incontinence – “involuntary leakage  of urine that is  preceded by urgency” 
Frequency :day time frequency is the number of times a women voids during working 
hours.Normal diurnal frequency is considered to be between 4-7 voids per day 
Nocturia :Defined as the complaint that the patient has to  wake up one or more times during 
night to void. 
Nocturnal enuresis is the complaints of urine occurring during sleep. 
Stress urinary incontinence: “Defined as the involuntary loss of urine with exertion or 
effort or with coughing and sneezing” 
Mixed urinary incontinence: women with mixed urinary incontinence statisfy the definition  
for  both stress and urge incontinence 
Coital incontinence:  IUGA/ICS defined as “ involuntary loss of urine associated with 
coitus”. This is further subdivided in to “incontinence with penetration or with orgasm”.  And  
incontinence during orgasm is related to OAB. 
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Insensible incontinence: The IUGA/ICS defines insensible in continence as the complaints 
of urinary incontinence  where the women is  unaware of how it occurred 
Hesitancy :Defined as “difficulty in initiation of micturition resulting in a delay of the onset 
of  voiding  after she is ready to pass urine”. 
Straining to void Describes “the muscular effort used to initiate ,maintain,or improve the 
urinary stream”. 
Incomplete emptying: “Feeling of incomplete emptying  experienced by the individual after 
passing urine” 
Post micturition dribble: Is defined as “involuntary loss of urine  immediately after passing 
urine” 
Slow stream: Defined as “the individual perception of reduced urine flow” 
Position dependent micturition: Defined as the complaint of having to adopt specific 
positions to be able to micturate spontaneously or improve bladder emptying.(squatting, 
leaning forward, leaning backward) 
Pelvic organ prolapse  often co-exits and may contribute to lower urinary tract  symptoms. 
Women may describe the learned behavior of using their fingers to reduce the bulge in order 
to successfully micturate or defecate which is referred to as digitation. Over 40% of women 
with urethral sphincter incompetence will also have significant cystocele. Vaginal prolapse 
can mask urethral sphincter incompetence and when the prolapse is reduced the urethral 
incompetence is revealed . [46]. This is referred to as Occult incontinence. 
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Women with higher stage  III or IV of pelvic organ  prolapse are more likely to have  greater  
symptoms of voiding dysfunction than those with stage I or II POP (44% vs. 9%). 
Urodynamic evaluation  showed  that 72% of women with advanced prolapse had urethral 
obstruction compared  6% in stage  1 or 2 POP. None of the patients with Stage 3 or 4 POP 
demonstrated urodynamic stress incontinence, whereas 86% of those with stage1or 2 POP 
did. As many as 30% of women with stage 3 or 4 prolapse have elevated postvoid residuals 
(PVR>100 cc)  [46]. 
 Women with advanced prolapse have lower mean and maximum flow rates than women 
with urinary incontinence. Despite this objective evidence of voiding dysfunction in women 
with advanced prolapse. The correlation between specific voiding symptoms such as 
hesitancy, weak stream, and feeling of incomplete emptying and severity of prolapse is weak. 
Voiding dysfunction symptoms, particularly the need to splint to urinate, appears to resolve 
after prolapse surgery in the majority of women who report these symptoms preoperatively. 
[47]. 
.  
Defecatory symptoms:  
POP patients frequently report symptoms related to bowel dysfunction, includes “feeling of 
incomplete rectal emptying, hard straining to defecate, the need to apply digital pressure to 
the vagina or perineum (splint) to start or complete defecation, fecal urgency, and 
incontinence of flatus or stool”[48]. 
The most common bowel symptom associated with prolapse is constipation .Defecatory 
symptoms may be present in women with any anatomic site of prolapse, although they tend 
to be found more commonly associated with posterior or apical defects [49,50]. In the study 
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of women presenting to a pelvic floor clinic described above, women with stage I prolapse 
were the least likely to require splinting to defecate (8 to 15 percent), but the likelihood of 
splinting symptoms did not continue to increase with advancing prolapse (stage II: 21 to 38 
percent; stage III to IV: 2.6 to 29 percent) [51,52].  
Studies evaluating the relationship between pelvic organ prolapse and defecatory symptoms 
have several limitations.  
 Assessment of posterior compartment support is challenging There is no clear  
guidelines  whether physical examination or radiologic evaluation should be used to 
assess the anatomic and functional relationship of the posterior compartment. Studies 
that based  on physical examination alone to evaluate posterior vaginal support and 
compared  to defecography have demonstrated high sensitivities(91%–94%) for the 
detection of rectocele. However, physical examination fails to detect enteroceles or 
sigmoidoceles detected during proctography in approximately 50%of cases in patients 
with severe prolapse.[53]. 
The presence of enterocele or sigmoidocele  causing  bowel disorders in women with 
posterior vaginal prolapse is currently unknown. The ‘‘gold standard’’ method   for 
anatomic evaluation posterior compartment defects is defecography . However this  is 
not  ideal, as it has lost of false positive results and  normal asymptomatic women 
demonstrate focal defecographic abnormalities. 
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 The radiographic criteria used to define significant rectocele at proctography (≥3 cm) 
also     did not correlated defecatory symptoms. 
 The second limitation was  to evaluate the effect of prolapse surgery on bowel 
function, due to poorly defined terms such as ‘‘constipation’’ or ‘‘defecatory 
dysfunction,’’ and non-availability  of  standard definitions of constipation or its 
subtypes  in women with pelvic floor disorders 
 
Constipation  
Constipation is a symptom with many different definitions “based on stool frequency, 
consistency, the need for straining, incomplete emptying”, Classification of constipation 
based on the  ROME II criteria . 
 
 
 
 
Functional constipation demonstrated   delay in   transit times on colonic transit 
studies. The outlet-type constipation, was described as constipation—predominant IBS or 
functional constipation along with one of the following  symptoms   
 
 
 
 constipation—predominant “irritable bowel syndrome “  
functional constipation 
 pelvic floor dyssynergia. 
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1.A sensation that stool cannot be passed when having a bowel movement, a need to 
press on or around their bottom or vagina to try to remove stool to complete a bowel 
movement, 
2.  Difficulty relaxing or letting go to allow the stool to come out at least one fourth 
of the time. 
  Cleveland Clinic experience, outlet-type constipation found to be the predominant 
subtype seen in patients with pelvic organ prolapse and urinary incontinence. Interestingly, 
the prevalence of all types of constipation, and outlet-type in particular, were not different 
between those patients with stage 3 or 4 pelvic organ prolapse and those with urinary 
incontinence without prolapse [54]. A case–control study compared  women with 
uterovaginal prolapse and urinary incontinence with normal control women  reported that 
61% of womenwith uterovaginal prolapse  complained straining  at stool as a young adult 
compared with 30% of women with stress incontinence and 4% of normal control 
women.[55]. 
 Outlet-type constipation is commonly associated with pelvic organ prolapse and urinary 
incontinence. Multiple causes for defecatory symptoms to be considered in women with 
pelvic organ prolapse because defecatory dysfunction may be a cause of prolapse rather than 
a consequence, and specific bowel symptoms correlate poorly with worsening prolapse.  
Furthermore, its important that women with pelvic organ prolapse should be counseled prior 
to surgery that surgical correction of prolapse may not improve defecatory symptoms. 
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Effects on sexual function: 
Pelvic organ prolapse is common in elderly age group, assessing the relationship between 
pelvic organ prolapse and sexual function, it is difficult to separate the effects of pelvic organ 
prolapse from the normal changes associated with aging and menopause . Literature showed 
that sexual function  assessment in women with pelvic organ prolapse are  mostly  limited by 
their small sample size, retrospective nature, and failure to use validated sexual function 
questionnaires. Very few papers have compared sexual function in women with prolapse 
with similarly aged women without prolapse. However, existing evidence suggests that, in 
general, women with pelvic organ prolapse have similar rates of sexual activity as similarly 
aged women without pelvic organ prolapse [56]. 
The most common reason for sexual inactivity in this population is absence of a male 
partner.[57,58 ]Of those with a partner, male sexual dysfunction, particularly erectile 
dysfunction, is the most often cited reason for inactivity[59] In 1 study, women with prolapse 
or detrusor instability were more likely to cite their pelvic floor symptoms as a reason for 
sexual inactivity than women with stress urinary incontinence or mixed incontinence[59] . 
Among sexually active women with prolapse, approximately one third report that their 
prolapse interferes with their sexual function [57,58 ] . 
Ellerkmann et al found that impairment of sexual activity was moderately associated with 
worsening prolapse in all 3 vaginal compartments, with the apical prolapse being the most 
pronounced[48 ]. However, the only study thus far that has compared sexual function in 
women with prolapse with that of women without prolapse using a validated sexual function 
questionnaire found no difference in frequency of intercourse, libido, vaginal dryness, 
dyspareunia, orgasmic function, or overallsexual function between the 2 groups[57]. 
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Furthermore, there is a high rate of sexual satisfaction (81%–84%) in women with 
pelvic organ prolapse who are in an intimate relationship. [57,59] . The majority of studies of 
sexual function in patients with prolapse have focused on the effect of vaginal reconstructive 
surgery on vaginal length and caliber or on postoperative sexual functioning, particularly 
dyspareunia. Most prospective studies demonstrate that sexual function either does not 
change or improves in the majority of women after vaginal reconstructive surgery for pelvic 
organ prolapse [58,59] .   Vaginal length and caliber appear to have little relationship with 
postoperative sexual satisfaction. However women who undergo posterior colporrhaphy 
especially in conjunction with Burch colposuspension, are at increased risk of developing 
dyspareunia, with rates as high as38%. [58] 
  Prolapse does not appear to be associated with decreased sexual desire or with 
dyspareunia, although reports vary according to whether POP is associated with adverse 
effects on orgasm or sexual satisfaction [58]. Some women report that they avoid sexual 
activity because of fear of discomfort or embarrassment associated with POP, particularly 
those with urinary or fecal incontinence during sexual activity [59]. 
Various Questionnaires are used to assess the voiding and defecatrory dysfunctiions in 
women with POP 
Questionnaires can be divided into 3 categories: 
1)  Measure of  presence of particular symptoms and their    
 severity (Symptom questionnaires);  
2) Measure quality of life (Quality-of-Life [QOL] questionnaires),  
 3)  Measure sexual function (Sexual Function questionnaires). 
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 Questionnaire development is a complex process that is governed by the principles of 
psychometrics. Psychometrics is the science of the measurement of responses to phenomena 
that are not easily quantifiable.  
Questionnaire must demonstrate 3 important psychometric properties: validity, 
reliability, and responsiveness. The validity of a questionnaire is simply whether it 
measures what is intended. The reliability of a questionnaire refers to its ability to measure 
in a reproducible fashion. Responsiveness refers to a questionnaire’s ability to reliably detect 
the overall effect of treatment and ability to detect clinically meaningful change. 
Questionnaire with good psychometric properties, said to be ‘‘validated.’’ Other 
characteristics that are desirable in a questionnaire include being easy to understand and 
feasible to implement. Symptom questionnaires are used to assess the presence, severity, 
and impact of particular symptoms or groups of symptoms.  
Pelvic Floor Distress Inventory questionnaire is the valid and reliable symptom 
questionnaire designed   for women with pelvic organ prolapse .This comprehensive 
symptom questionnaire is intended for women with all forms of pelvic floor disorders. It 
assesses 46 pelvic floor symptoms and has 3 scales: a urinary scale (identical to the UDI), a 
colorectal scale, and a pelvic organ prolapse scale. Patients are asked to indicate if they have 
a particular symptom and if so, they are asked to assess how much it bothers them on a 4-
point scale.  
Short version of the PFDI: The Pelvic Floor Distress Inventory short form 20 (PFDI-20), 
which also has urinary, colorectal, and pelvic organ prolapse scales. The urinary scale of the 
PFDI-20 is identical to the UDI-6. Both the PFDI and the PFDI-20 have good reliability and 
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validity and have demonstrated excellent responsiveness in patients undergoing surgery for 
pelvic organ prolapse [60]. 
. 
The International Prostate Symptom Score (I-PSS): is based on the answers to 
eight questions in which 7 questions are regarding to urinary symptoms and 1 question about 
quality of life. Each question related to urinary symptoms were allowed to choose by the 
patients, one out of six answers indicating increasing severity of the concern symptom. The 
answers are assigned points from 0 to 5. The total score ranges from 0 to 35 (asymptomatic 
to very symptomatic).  
The questions refer to the following urinary symptoms as follows; 
Questions Symptom 
1. Incomplete emptying 
 2.  Frequency 
3.  Intermittency 
4.  Urgency  
5.  Weak Stream 
 6.  Straining  
7.  Nocturia  
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8
th
 Question refers to the patient’s quality of life. The  first seven questions of the I-
PSS are similar to the questions appearing on the American Urological Association (AUA) 
Symptom Index which currently classifies symptoms as follows: 
 IPSS 7-urinary symptom score 
 
 
 
 
The International Scientific Committee (SCI), World Health Organization (WHO) 
and the International Union Against Cancer (UICC) guidelines recommends the use of single 
question to assess the QOL. The answers to this question range from 0 to 6 implies 
“delighted” to “terrible” [61].   
Scarpero et al. reported that the IPSS precisely explains both the female LUTS as 
well as male LUTS and predict the degree of bother and effect on quality of life (QOL) [62].  
Recently, the IPSS has been proven to have excellent internal consistency and good 
constructive validity in assessing female LUTS [61].   
The pelvic organ prolapse Quantification (POP-Q) classification system involves the 
description of dimension of the vagina and perineum and of the topography of the anterior 
and posterior vaginal walls. POP-Q measurements corresponds to stages (0-4) of prolapse in 
each compartment (anterior, apical, and posterior) of vagina. 
symptoms score 
Mild 0-7 
Moderate 8-19 
Severe 20-35 
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Figure 10. POP-Q points 
Point Aa: Point that lies in the midline of anterior vaginal wall and is 3cm proximal 
to the external urethral meatus.  
Point Ba: represent the most distal portion the remaining upper anterior vaginal wall  
Point Ap: Posterior vaginal wall 3 cm proximal to the hymen  
Point Bp: Most distal position of the remaining upper posterior vaginal wall others  
Point C : Cervix or vaginal cuff 
Point D:Posterior fornix or vaginal apex 
Genital hiatus (gh):External urethral orifice to posterior hymenal remant 
Total vaginal length(TVL):Hymenal ring to point D 
Perineal body (pb):Posterior hymen to middle of anal opening 
 
STAGES OF PROLAPSE: 
            STAGE 0 : No prolapse. Apex can descend within 2cm above the hymen. 
STAGE I : Leading edge is >1 cm above the level of hymen 
STAGE II : Leading edge descends to within 1cm of plane of hymen ( above or 
below) 
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STAGE III :Leading edge descends > 1cm beyond hymen but no further  than 2 cm 
less than the total vaginal length. 
 
STAGE IV: Complete eversion .Leading point > + (TVL-2) cm. 
  
 
 
 
Fig 11 : Diagram of Stages of prolapse 
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Several studies have shown anterior wall defects associated with voiding dysfunction and 
perineal, posterior  vaginal support defect with defecatory dysfunction in urogynaecology  
patients. The POP-Q Bp points, not the pb measurement, correlates with symptoms of 
defecatory dysfunction . 
Uroflowmetry 
International continence society defined Urodynamics as observation made during  
Urodynamic  studies.  And Uroflowmetry should always be interpreted with clinical 
information. European   Association of urology guidelines recommends Uroflometry for 
women with significant pelvic organ prolapse. 
ICS working party on urodynamic equipment   described  three methods of 
Uroflow meter  as follows 
1.The gravimetric method 
2.The Electronic dip stick method 
3.The rotating Dip stick method 
Following parameters are calculated in uroflowmetry 
Voided volume: The volume of total voided urine expelled from the bladder 
Residual urine volume:  Amount of   urine remaining in the bladder after complete  void 
Flow time: The time  during which measurable flow actually   occurs 
Maximum flow rate (Qmax): The maximum measured value of the flow rate 
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Time to maximum flow: The time between the onset of  flow to the point of maximum flow 
Mean flow rate: Volume voided divided by flow time. 
Normal flow curve is a bell shaped, continuous, smooth curve with a increasing flow rate 
Voided volume more than 150 ml and Qmax more than 15ml/sec considered normal. 
 
 
 
 
 
 
 
Fig12:Uroflow curve 
In Pelvic organ prolapse maximal flow rate and average flow rate were significantly less 
compared to normal healthy individuals. 
Several studies have shown that women with severe POP  have  abnormal 
urodynamics despite the absence of subjective symptoms. Most of the patients with high-
stage cystocele have shown that obstructive uroflow  which implies high urethral resistance 
owing to compression of the urethra by the cystocele . 
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 Detrusor hypocontractility may be more common in patients with high-stage 
cystocele because the detrusor function gradually becomes weaker as a long-term effect of 
voiding against resistance [51,63].    
 
PVR (Post void residual urine) 
Measuring amount of residual urine in the bladder after a voluntary void is 
defined as post void residual urine volume (PVR). Portable bladder scanners are 
convenient, accurate, cost-effective and non-invasive screening test for evaluating 
voiding dysfunction [64]. Threshold values for abnormal post void residue are not 
clearly defined. The volumes of 50 ml to 100 ml are considered as abnormal residual 
urine volume by most urologists. 
 
 Fig 13: Ultrasound measurement of bladder volume in sagittal and transverse 
planes 
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There is an increased risk of upper urinary tract dilation and renal insufficiency with 
very large post void residue (>300 ml) .Large post void residue may be caused by bladder 
hypo contractility. Poor bladder contractility may result from neurogenic, myogenic, 
psychogenic, or pharmacologic causes[64].  
Management: Treatment is indicated for women with symptoms of prolapse or associated 
conditions (urinary, bowel, or sexual dysfunction). Obstructed urination or defecation or 
hydronephrosis from chronic ureteral kinking are all indications for treatment, regardless of 
degree of prolapse [65]. Treatment is generally not indicated for women with asymptomatic 
prolapse [66]. 
Management options: Women with symptomatic prolapse can be managed expectantly, or 
treated with conservative or surgical therapy. Both conservative and surgical treatment 
options should be offered. There are no high quality data comparing these two approaches. 
The choice of therapy depends upon the patient’s preferences, as well as the ability to 
comply with conservative therapy or tolerate surgery. Some data suggest that age, the degree 
of POP as measured by descent of leading edge of prolapse, preoperative pelvic pain scores, 
and prior prolapse surgery are independently associated with treatment choices. In a study of 
152 women, older patients and those with increased preoperative pelvic pain scores were 
more likely to choose pessary over surgery [66]. On the other hand, the likelihood of 
choosing surgery was increased in women with more severe prolapse or a prior POP repair. 
Expectant management — Expectant management is a viable option for women who  can 
tolerate their symptoms and prefer to avoid treatment. Women with symptomatic or 
asymptomatic prolapse who decline treatment, particularly stage III or IV, should be 
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evaluated on a regular basis to assess for the development or worsening of urinary or 
defecatory symptoms and/or findings. 
Conservative management : In POP Conservative therapy is the first line choice  since 
surgical treatment suffers the risk of complications and recurrence [67]. However, prolapse is 
naturally a chronic problem, and many women ultimately prefer surgery to conservative 
therapy since effective surgery does not require ongoing maintenance. 
Vaginal pessary:The main stay of non-surgical treatment for POP is the vaginal pessary.  In 
elderly women  with co morbid medical conditions   confers a significant risk for surgical 
morbidity and mortality.  
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Various types of pessaries 
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The reported surveys showed 87% to 98% of gynecologists were  using pessaries for  
conservative management[68-69] .  Pessaries are silicone devices and are available in various 
shapes and sizes, which support the pelvic organs. About half of the women who use a 
pessary continue to do so in the intermediate term of one to two years. Pessaries needs to be 
removed and cleaned on a regular basis. Gynaecologist have  reported the decrease in 
prolapse stage after long-term pessary use and the prosperous role of pessaries in preventing 
progression of prolapse. 
Pelvic floor muscle exercises:  Pelvic floor muscle exercises (PFME) appear to 
result in improvements in POP stage and POP-associated symptoms. Studies  have 
demonstrated the benefit of PFME, particularly with individualized training and/or 
supervision [70-71]. As an example, one trial included 109 women with stage I to III 
prolapse who were assigned to either PFME for six months with regular supervision by a 
physical therapist or to a control group [70-71]. Women in the PFME group had significant 
reductions in the frequency and bother of most prolapse, bladder, and bowel symptoms 
(exceptions were urgency urinary incontinence symptoms, difficulty with stool emptying, 
and solid stool fecal incontinence). Improvement in POP stage was found more frequently in 
the PFME group (19 versus 8 percent). Further study is needed of the effect of PFME on 
POP. 
Surgical treatment: Surgical candidates include women with symptomatic prolapse not had 
improvement in their symptoms on conservative management of their prolapse There are 
many surgeries for prolapse which includes  vaginal and abdominal approaches with and 
without graft materials. Surgical prognosis depends upon the severity of symptoms, extent of 
the prolapse, physician experience, and patient expectations 
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 Surgical management of pelvic organ prolapse can be challenging, because multiple 
support defects frequently coexist. It is rare to find isolated defects in the anterior or posterior 
compartments without also finding an apical defect. 
Apical compartment 
 Many experts would argue that adequate suspension of the apex is the cornerstone of 
a successful prolapse repair. If the muscularis layer of the vaginal tube is intact and the apex 
is well suspended, many anterior and posterior defects will also resolve. This is evident by 
the numerous reports of successful anatomic outcomes after repair of stage IV prolapse by 
simply suspending the apex at the time of colpopexy without  concomitant repairs[72].. 
 
 
Figure 15.  Algorithum for management of apical compartment defect 
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Anterior compartment 
Evaluation and repair of the anterior vaginal wall represents a surgical challenge for 
the pelvic reconstructive surgeon. Careful evaluation evaluation of defects preoperatively 
must be coupled with intraoperative assessment for optimum repair. Often multiple sites 
must be addressed to reestablish support and bladder function must always be considered 
along with anatomic reconstruction. 
Surgery has traditionally been associated with a recurrence/reoperation rate of up to 30 
percent after the initial surgery [73], with some centers reporting reoperation in over 50 
percent of patients who have undergone at least two prior surgical procedures for prolapse 
[74]. 
Posterior compartment 
Compared with the traditional colporrhaphy, which assumes that the anatomic defect 
is the result of stretching of the rectovaginal septum or vaginal muscularis, the site-specific 
technique is based on the assumption that discrete tears of these layers result in posterior wall 
prolapse. Possibly as a resultof the general idea that plication of tissue to the midline does not 
restore ‘‘normal anatomy,’’many surgeons have abandoned the colporrhaphy technique in 
favor of the site-specific defect repair[75]. Like with many surgical conditions, the most 
important preoperative goal should be to help each patient to have realistic preoperative 
expectations. 
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ABBREVIATIONS 
POP-PELVIC ORGAN PROLAPSE 
VD- VOIDING DYSFUNCTION 
DD –DEFECATORY DYSFUNCTION 
POP-Q-PELVIC ORGAN PROLAPSE QUANTIFICALTION SYSTEM 
QMAX-MAXIMAL FLOW RATE 
PVR-POST VOID RESIDUAL URINE 
IPSS-INTERNATIONAL PROSTATE SYMPTOM SCORE 
PFDI-20-PELVIC FLOOR DISTRESS INVENTORY SCORE 
CRADI-8  -COLORECTAL DISTRESS INVENTORY SCORE 
LUTS-LOWER URINARY TRACT SYMPTOMS 
QOL-QUALITY OF LIFE 
VH-VAGINAL HYSTERECTOMY 
PFR-PELVIC FLOOR REPAIR 
 P VALUE- CALCULATED PROBABILITY VALUE 
OR- ODDS RATIO 
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MATERIALS AND METHODS 
 
Research design: This is a cross sectional   study done in Christian Medical College and 
Hospital Vellore, India. 
 
Study period    October  2015 To august 2016 
 
Study Setting:  This study was conducted in the department of obstetrics and  
Gynaecology in patients   at Christian Medical College and Hospital Vellore. 
 
The Study was approved by institutional   review board and ethics Committee of the 
Hospital. 
 
Inclusion criteria: 
 Postmenopausal women with Stage 2, 3 and 4 POP  
  Vault Prolpase 
 
   Exclusion criteria:  
 Women  with neurological disorder 
  Women with prior anti-incontinence or bowel surgery 
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During the study Period ,all the patients who fulfilled the eligibility criteria  were invited to 
participate. All the patients were explained about the nature of the study. An informed written 
consent was obtained from each patients . Postmenopausal women with POP stage 2, 3 ,4  and vault 
prolapse were admitted in gynaecology ward for pelvic reconstructive surgery were recruited and  
given a study number . 
 A detail history was taken   and women are interviewed by the principle investigator to 
complete the short form of pelvic floor distress inventory (PFDI-20) and International 
prostate symptom questionnaire I-PSS score for Lower urinary tract symptoms(LUTS). socio-
demographic and clinical details were also collected .All the patients maintained a 24 hours 
voiding diary. 
 Voiding diary parameters includes intake volume, voided volumes, and incontinent and 
urgency episodes, usage of pads, day and night frequency  and type of activities performed 
during these episodes documented by patients. 24 hrs urine production, nocturnal urine 
volume and maximum voided volume were  assessed from voiding dairy. 
  pelvic examination  done for all women with POP-Q staging system.Definition, and 
descriptions conformed to the standards recommended by the international continence 
society(ICS)  
POP-Quantification  
 Point Aa: Point that lies in the midline of anterior vaginal wall  and is 3cm proximal to 
the external urethral meatus.  
 Point Ba: Represent the most distal portion the remaining upper anterior vaginal wall  
 Point Ap: Posterior vaginal wall 3 cm proximal to the hymen  
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 Point Bp: Most distal position of the remaining upper posterior vaginal wall  
 Point C : Cervix or vaginal cuff 
 Point D: Posterior fornix or vaginal apex 
 Genital hiatus (gh): External urethral orifice to posterior hymenal remant 
 Total vaginal length(TVL): Hymenal ring to point D 
 Perineal body (pb): Posterior hymen to middle of anal opening 
 
 
STAGES OF PROLAPSE: 
STAGE 0 : No prolapse. Apex can descend within 2cm above the hymen. 
STAGE I: Leading edge is >1 cm above the level of hymen 
STAGE II: Leading edge descends to within 1cm of plane of hymen ( above or  
below) 
STAGE III :Leading edge descends > 1cm beyond hymen but no further  than 2 cm 
less than the total vaginal length. 
STAGE IV: Complete eversion. Leading point > + (TVL-2) cm. 
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The following investigations were done 
 Serum creatinine 
 Blood sugar fasting and post prandial 
 Urine microscopy 
 Urine culture was done in those women with significant white cell counts on urine 
microscopy 
 Uroflow and post void residual urine volume were measured 
 
PVR 
Post void residual volume was  measured with in 10 mints of voiding using a transabdominal 
scan.by measuring three orthogonal diameters of the bladder, the post void residual bladder volume 
was estimated and calculated by the formula 
Volume = (π × D1×D2×D3)/6 
D1- Widest diameter in the transverse scan (cm) 
D2- Antero posterior diameter in the longitudinal scan.(cm) 
D3- Cephalocaudal diameter in the longitudinal scan (cm) 
Π = 22/7 
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All patients who had high post void residual bladder volume were assessed again for PVR. 
Residual volume  more than 100 ml was taken as significant. This information enabled us to 
evaluate function as well as to find out an obstruction of lower urinary tract. 
Uroflow: 
Gravimetric method is used in our institute for uroflowmetry. 
This method measures the urine flow rate by measuring the weight of the collected fluid. The 
output electrical signal is directly related to the mass of fluid collected. 
Diagram of normal uroflow curve 
 
 
 
 
 
 
 
Fig 16. Diagram of normal uroflow curve 
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Voiding Dysfunction : Was defined as the presence of at least one of the  following criteria 
1. Maximal flow rate below 15ml/sec 
2. PVR >=100ml 
 
Fig17.. Diagrammatic representation of 
Uroflowmetry room in our department 
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The International Prostate Symptom Score (I-PSS): is based on the answers to eight questions in 
which 7 questions are regarding to urinary symptoms and 1 question about quality of life. Each 
question related to urinary symptoms were allowed to choose by the patients, one out of six answers 
indicating increasing severity of the concern symptom. The answers are assigned points from 0 to 5. 
The total score ranges from 0 to 35 (asymptomatic to very symptomatic). 
 
The questions refer to the following urinary symptoms as follows; 
Questions Symptom 
1. Incomplete emptying 
 2.  Frequency 
3.  Intermittency 
4.  Urgency  
5.  Weak Stream 
 6.  Straining  
7.  Nocturia  
 
8
th
 Question refers to the patient’s quality of life. The  first seven questions of the I-PSS are 
similar to the questions appearing on the American Urological Association (AUA) Symptom 
Index which currently classifies symptoms as follows: 
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 IPSS 7-urinary symptom score 
symptoms score 
Mild 0-7 
Moderate 8-19 
Severe 20-35 
 
The International Prostate Symptom Score (I-PSS)-for Quality of life assessment 
The International Scientific Committee (SCI), under the patronage of the World 
HealthOrganization (WHO) and the International Union Against Cancer (UICC), 
recommends the use of only a single question to assess the quality of life.  I-PSS - Question 
eight refers to the patient’s perceived quality of life. The answers to this question range from 
“delighted” to “terrible” or  score 0 to 6.  
In  our study we defined  quality of life as “satisfied”if the score is  less than 3 and the  
quality of life as “unsatisfied” if the score is 3 and above . 
Pelvic Floor Distress Inventory (PFDI-20)  
The short form of the Pelvic Floor Distress Inventory (PFDI-20) ,a condition-specific, 
validated, health related quality of life questionnaire with 3 subscales,which is designed to 
evaluate distress caused by specific pelvic floor symptoms including urinary ,bowel and 
pelvic organ prolapse symptoms.items on the PFDI-20 form first ask wheather each symptom 
is experienced or not(“yes” or “no” response),and if  “yes”, the degree of bother is assessed 
on the scale from 1(not at all)to 4(quite a bit). 
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Colorectal Anal Distress Inventory (CRADI-8)  
The overall degree of bother attributed to 8 bowel symptoms in women with pelvic organ 
prolapse is described by “the CRADI8(colorectal distress inventory-8)bowel subscale score 
with in PFDI-20(short form of the pelvic floor distress inventory)”.CRADI-8 form first ask 
whether each symptom is experienced or not(“yes” or “no” response),and if  “yes”, the 
degree of bother is assessed on the scale from 1(not at all)to 4(quite a bit). 
In our study we defined a negative response as either the report of “no “for the symptom or 
the report of “yes” but with a degree of bother specified as “not at all “or somewhat” 
A positive response was defined as the report of “moderately “or “quite a bit” of bother.  
In this  study we defined  defecatory dysfunction as “The women  who had   given positive 
response for 2 or more questions  out of 8 questions “in CRADI_8 bowel subscale score with 
in PFDI-20(short form of the pelvic floor distress inventory). 
All the study patients Underwent surgery as per the discretion of the surgeon. 
All the patients were  followed up on their 6
th
 post-operative  day and uro flow and PVR 
were done . pre and post-operative uroflow and PVR correlated . 
The information was computerised and confidentiality was maintained.  
Sample size calculation 
 The required sample size to show that about 40% of POP women will develop voidal 
dysfunction was found to be 120 women with 95% confidence limits and about 10%  
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precision. The 40% was considered as there were studies that showed voidal dysfunction to 
range from 30 to 50%. [76]. 
 
 Ref: European Journal of Obstetrics & Gynecology and Reproductive Biology 174  
2014) 146–149. 
Formula: 
 
 
 
 
Reference for formula: 
Lemeshow S, Hosmer D. W, Klar J, Lwanga S. K, Adequacy of Sample Size in 
Health Studies.  John Wiley and Sons, 1990. 
 
 
 
 
 
Expected  Proportion 0.4 0.4 0.4 
Precision (%) 10 7.5 9.5 
Desired confidence level  (1- alpha) % 95 95 95 
Required sample size 92 164 120 
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Presence or absence of voidal dysfunction was  calculated using maxium flow rate and/or 
PVR. Descriptive measures such as mean with SD and/or median with IQR was presented for 
all continuous variables whereas frequencies and percentages was presented for all 
categorical variables.  
All the categorical variables were associated with voidal dysfunction using Chi-square test 
with continuity correction and for small sample size Fisher’s exact test was used.  
All continuous variables were  compared across women with and without voidal dysfunction 
using independent t-test or Mann Whitney U test. The decision of choosing independent t-test 
or Mann Whitney U test was done on the basis of assumption of normality which was 
assessed by plotting QQ plot and histogram along with Shapiro Wilk test of significance for 
normality. 
 All those significant in the Chi-square test or independent t-test at p value ≤ 0.2 were taken 
for logistic regression analysis. SPSS version 21 was used for analysis and p value < 0.05 
was considered as statistically significant.  
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RESULTS  
This cross sectional study was conducted in the Department of Obstetrics and 
Gynaecology, Christian Medical College Hospital, Vellore between October 2015 to August 
2016. The study was approved by the institutional review board and ethical committee of the 
hospital. 
The calculated sample size for this study was 120 cases but this interim analysis was 
done for 60 cases. Sixty post-menopausal women with pelvic organ prolapse stage II, III and 
IV admitted in the ward for surgery were recruited after informed consent. All the sixty 
women were examined and interviewed with international prostate symptom score (IPSS) 
questionnaire and short form of pelvic floor distress inventory (sPFDI-20) questionnaire by 
the principal investigator. POP-Q system was used to stage the prolapse. In all 60 women  
pre and post-operative Uroflow and PVR were measured. 
Table1. Demographic  Data (n=60)  
Patient Characteristics 
 
Description 
(mean ± SD) 
Age (years)  58 ± 8.5 
BMI (kg/m²) 25 ± 4.8 
Parity  3 ± 1.43 
Duration of menopause( months)  136 ± 96.05 
Duration of prolapse ( months)  59 ± 77.96 
 
In 60 patients the mean age ,BMI, Parity were 58yrs, 25.kg/m², 
3children,respectively.The mean duration of menopause and prolapse were 136  , 59 months 
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respectively. Women with co-morbidites were studied ,30% (n=18) of women had diabetes, 
25% (n=15) had hypertension and 5% (n=3) had chronic cough.  
Table 2.Voiding Dysfunction 
Patient Characteristics Description 
(mean ± 
SD)/%(n) 
Pre op Q max (ml/sec) 17 ± 7.49 
Pre op PVR (ml) 83 ± 38.51 
Post op Q max (ml/sec) 22 ± 4.50 
Post OP PVR (ml) 46 ± 31.35 
Voiding dysfunction 68(41) 
 
The  pre and post  Operative  Q max were 17and 22 ml/sec respectively.  The observed pre 
and postoperative PVR were was 83 and 46ml respectively. The overall prevalence of pre-
operative voiding dysfunction was 68 % ( n=41) . 
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            Fig18. Prevalence of Voiding dysfunction 
Table 3.   Stage of prolapse  and POP-Qpoints  
Patient Characteristics Description 
%(n)/mean±SD 
 
Stage II POP 
 
8 (5) 
Stage III POP 80(48)  
Stage IV POP 12 (7) 
Anterior compartment 97(58) 
Posterior compartment 73(44) 
Apical compartment 87(52) 
Point Aa (cm) 1.8 ± 1.67 
Point Ba (cm) 3.2 ±1.92 
Point Ap (cm) -0.5 ± 2.24 
Point Bp (cm) 0.35 ±2.64 
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The prevalence of stage II, III and IV POP were 8% (n=5), 80% (n=48), 12% (n=7) 
respectively. Anterior compartment defect was noticed in 97 % ( n=58), posterior 
compartment  in73 % ( n=44) and apical compartment in 87 % (n= 52).The mean  POP-Q 
points in cm were point Aa  1.8  point Ba  3.2 cms .The posterior compartment point 
measurements of point Ap and BP were  -0.5 , 0.35 cm respectively.  
 
 
Table 4. Correlation of stage of prolapse with voiding dysfunction 
Stage of 
prolapse 
VD Present % 
(n) 
VD Absent 
% (n) 
P value 
Stage II 60(3) 40(2)  
0.050 Stage III 65(31) 35(17) 
Stage IV 100(7) 0 
Total 68(41) 32(19) 
Voiding dysfunction was defined as presence of at least one of the following criteria 
Maximal flow rate (Qmax)< 15 ml/s or PVR ≥ 100ml.  
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Fig19.. correlation  between stages of prolapse and voiding dysfunction 
 
The prevalence of voiding dysfunction in stage II, Stage III  and stage IV prolapse were 60% 
(n=3), 65%(n=31) and 100% (n=7) respectively. However, all  women with stage IV POP 
had voiding dysfunction with significant P value.(p=  0.050).  
Table 5. Correlation of compartment of prolapse with voiding dysfunction 
Compartment VD Present 
%(n) 
VD Absent 
%(n) 
P 
value 
OR CI (95%) 
Anterior (n=58) 69(40) 31(18) 0.537 2.222 0.132-37.547 
Posterior (n=44) 70(31) 30(13) 0.550 1.431 0.430-4.758 
Apical (n=52) 69(36) 31(16) 0.699 1.350 0.287-6.346 
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The prevalence of voiding dysfunction in the anterior compartment prolapse was 69 % ( 
n=40), posterior 70% (n= 31) and apical compartment was 69 % (n= 36). Women with 
anterior compartment prolapse had more voiding dysfunction with the odds ratio of 2.22 
(95% CI=0.13-37.55). However the p value was not significant (p=0.537).  
The overall degree of bother attributed to 8 bowel symptoms in women with pelvic organ 
prolapse is described by the” CRADI 8 (colorectal distress inventory-8) bowel subscale score 
with in PFDI-20 (short form of the pelvic floor distress inventory)”.CRADI-8 form first ask 
whether each symptom is experienced or not(“yes” or “no” response) and if  “yes”, the 
degree of bother is assessed on the scale from 1(not at all) to 4(quite a bit). 
 
Table 6. Correlation of stage of prolapse with defecatory dysfunction 
Stage POP DD present  
% (n) 
DD absent  
% (n) 
P value 
Stage II (n=5) 60(3) 40(2)  
Stage III (n=48) 58(28) 42(20) 0.797 
Stage IV(n=7) 71(5) 29(2)  
 
In this study we defined a “negative response” as either the report of “no” for the 
symptom or the report of “yes” but with a degree of bother specified as “not at all” or 
65 
 
somewhat” and “positive response” was defined as the report of “moderately” or “quite a 
bit” of bother. The   defecatory dysfunction was defined as “the women who had   given 
positive response for 2 or more questions out of 8 questions” in CRADI-8 bowel subscale 
score with in PFDI-20 (short form of the pelvic floor distress inventory). 
The overall prevalence of defecatory dysfunction in this study was 60% (n=36). In 
stage IV pelvic organ prolapse 71% (n=5) had defecatory dysfunction compared to 60% 
(n=3) in   stage II POP and 58% (n=28) in stage III pelvic organ prolapse. However,  P value 
was not significant (p=0.79).  
 
Table 7. Correlation of compartment of prolapse with defecatory dysfunction(DD) 
Compartments 
of prolapse 
DD %(n) 
Present 
DD %(n) 
Absent 
P value OR CI (95%) 
Anterior (n=58) 60(35) 40(23) 1 1.522 .091-25.563 
Posterior (n=44) 66(29) 34(15) 0.145 2.486 0.773-7.993 
Apical (n=52) 62(32) 38(20) 0.702 1.600 0.359-7.130 
 
In posterior compartment defect 66 % (n=29) of women had defecatory dysfunction 
compared to 60% (n=35) with anterior  and 62% (n=32) with apical compartment defect. 
Women with posterior compartment defect had more defecatory dysfunction with the odds 
ratio of 2.49 (95% CI=0.773-7.993).However the calculated p value was not significant 
(p=0.145). 
66 
 
 
Table 8: Correlation of  stage of POP with LUTS using I-PSS score 
Stage of prolapse IPSS score 
mild %(n) 
Moderate 
%(n) 
Severe 
%(n) 
P value 
 
 
0.475 
Stage II (n=5) 0 20(1) 80(4) 
Stage III (n=48) 2(1) 35(17) 63(30) 
 Stage IV (n=7) 14.3(1) 14.3(1) 71.4(5) 
The International Prostate Symptom Score (IPSS) -Mild (symptom score less than equal to 
7), Moderate (symptom score range 8-19), Severe (symptom score range 20-35). 
  
In this study a total of  80%(n=4) of  stage II  ,63% (n=30)of stage III and 71.4% (n=5)of 
stage IV POP showed ≥20 International Prostate Symptom Score (severe LUTS ). However 
the P value was not significant(p= 0.475 ) 
 
Table 9. Correlation of  stage of prolapse with QOL using I-PSS score 
Stage of POP Satisfied %(n) Unsatisfied %(n) P value 
Stage II(n=5) 40(2) 60(3)  
 Stage III(n=48) 12.5(6) 87.5(42) 0.248 
Stage IV(n=7) 29(2) 71(5)  
I-PSS - Question eight refers to the patient’s perceived quality of life. The answers to this 
question range from “delighted” to “terrible” or  score 0 to 6.   
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Fig20. Correlation between stages of prolapse and quality of life 
 
In  this study we defined  quality of life as “satisfied” if the score is  less than 3 and  
“unsatisfied” if the score is 3 and above.  
And  we observed that 87.5%(42) of women  in stage III POP  had unsatisfied quality of life 
compared to 71%(5) in stage IV and 60%(3) in stage II POP. However the  P value  was not 
significant (P= 0.248).  
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Table 10. Correlation of  stage of prolapse with pre and post operative Q max and PVR 
Stage of 
prolapse 
Qmax < 15ml/sec PVR > 100ml 
Pre op %(n) 
 
Post op %(n) Pre op %(n) 
 
Post op %(n) 
 
StageII 
(n=5) 
40(2) 0 20(1) 20(1) 
stageIII 
(n=48) 
42(20) 2(1) 50(24) 4(2) 
Stage IV 
(n=7) 
71(5) 0 71(5) 14(1) 
Total  
(n=60) 
45(27) 2(1) 50(30) 7(4) 
Qmax-maximal flow rate, PVR-Post void residual urine 
It was noticed 40% (n=2) of stage II POP and 71% (n=5) stage IV had pre operative 
Qmax <15 ml/sec, which was completely resolved after vaginal hysterectomy with pelvic 
floor repair. In stage III 42%(n=20) had pre op Qmax<15ml/sec , in which complete 
resolution was achieved in that 98%(n=19) . 
 Similarly 50%(n=24) in stage III and 71%(n=5) in stage IV POP  had elevated  pre-
operative PVR which resolved post operatively in 96%(n=22)in stageIII and 86%(n=4)in 
stageIV POP respectively.  
Table 11.Correlation of pre-operative voiding dysfunction with post-operative 
 voiding dysfunction 
 
Preop VD  Post op VD  
Yes %(n) 
Post op VD  
No %(n) 
P value 
YES(n=41) 7(3) 93(38)  
< 0.000 No(n=19) 10.5(2) 89.5(17) 
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Total of 68%(n=41)of women in our study had pre operative voiding dysfunction , In93%(n= 
38 )of women voiding dysfunction resolved after vaginal hysterectomy with pelvic floor 
repair.   The  P value is highly significant (p value < 0.000) 
Table 12.  Correlation of POP-Q points with voiding dysfunction 
POPQ points in cm VD present mean ± SD VD absent mean ± SD P value 
Point Aa  1.9 ± 1.8 1.8 ± 1.6 0.37 
Point Ba 3.3 ± 2.0 3.0 ± 1.9 0.29 
Point Ap -0.3 ± 2.4 -0.9 ± 1.7 0.53 
Point Bp 0.7 ± 2.8 -0.5 ± 2.0 0.14 
 The mean value of POP-Q point with VD in point Aa  was1.9 ± 1.8, Point Ba 3.3±2.0, Point 
Ap -0.3±2.4 and Point Bp was 0.7±2.8. However,  statistical significance could not be obtained. 
 Table 13 Correlation of POP-Q points with defecatory dysfunction 
POPQ points in cm DD present mean ± SD DD absent mean ± SD P value 
Point Aa  2.02±1.6 1.6±1.8 0.40 
Point Ba 3.2±1.9 3.3±2.0 0.79 
Point Ap 0.0±2.4 -1.3±1.7 0.02 
Point Bp 0.9±2.7 -0.5±2.4 0.04 
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 The mean value of POP-Q point in cm were point Aa 2.02 , Point Ba 3.2, Point Ap 
0.0 and Point Bp 0.9 . The Point Ap and Point Bp   were significantly correlates with 
defecatory dysfunction  with the significant P values of 0.02 and 0.04 respectively.  
 To sum up the results of this study  the overall   prevalence of voiding dysfunction in this 
study was 68% and the defecatory dysfunction was 60%.The stage of the prolapse correlates 
with  voiding dysfunction the  P value  0.050 was significant. Women with anterior 
compartment prolapse had more voiding dysfunction with the odds ratio of 2.22(95% 
CI=0.13-37.55).However the p value was not significant (p=0.537). 
The women with posterior compartment defect had more defecatory dysfunction with 
the odds ratio of 2.49(95% CI=0.773-7.993).However the calculated P value was not 
significant (p=0.145).Stage of POP not correlated with severity of LUTS the   P value was 
not significant (p= 0.475). Stage of prolapse not correlated with QOL the  P value was not 
significant (P=0.248).Preoperative voiding dysfunction   resolved post operatively in 93% of 
women and the calculated P value <0.000 was highly significant .The POP-Q Point Ap and 
Point Bp   were significantly longer in  women with DD  (P= of 0.02 and P=0.04). 
Interim analysis of this study with the relatively small number of patients made it 
challenging to define the exact correlation between stage of prolapse with voiding 
and,defecatory dysfunction. 
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Discussion 
Pelvic organ prolapse is a common problem in women and particularly in menopausal 
women having negative impact on quality of life. As life expectancy increases, POP acquires 
a greater significance. 20% of women in UK are awaiting  for prolapse surgery 
demonstrating the enormity of this virtual pandemic [26]. Studies shows the overall 
incidence of POP were more than 10% in the western world and the mean prevalence of 
pelvic organ prolapse were about 19.7% in the Indian subcontinent. The lifetime risk of 
undergoing an operation for prolapse or incontinence by 80 yrs.  is 11.1%[11] 
‘Voiding dysfunction’ (VD) is defined as a diagnosis by symptoms and urodynamic 
investigations as abnormally slow and/or incomplete micturition as per the International 
Continence Society guidelines [25]. In our study we defined Voiding dysfunction as Q max 
<15ml/sec or PVR>100ml. 
‘Defecatory dysfunction’ is characterized by a spectrum of anatomic and functional 
abnormalities that can lead to fecal incontinence or incomplete evacuation. In our study the   
defecatory dysfunction was defined as “the women who had   given positive response for 2 
or more questions out of 8 questions” in CRADI-8 bowel subscale score with in PFDI-20 
(short form of the pelvic floor distress inventory).  
Stage of prolapse with voiding dysfunction 
The reported prevalence of voiding dysfunction was 55% among women with high 
stage cystocele  [76]. Romanzi et al studied the effect of genital prolapse on voiding 
dysfunction  and reported that women with stage III and IV POP had more voiding 
dysfunction compared to lesser degree of prolapse (44% vs. 9%) [46]. In this study the 
overall prevalence of pre-operative Voiding dysfunction  was 68% . Women with stage II 
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and III  and IV prolapse the Voiding dysfunction  was reported in  60%, 64.6% and 100% 
respectively. Stage IV POP had more voiding dysfunction with the statistically significant P 
value (P=0.05). The possible explanation could be detrusor hypo contractility as a long term 
effect of voiding against resistance[76]. 
Compartment of prolapse with Voiding dysfunction 
Jiyunchae et al. reported  the POP-Q stage specially  the anterior compartment 
prolapse  had greater incidence of voiding dysfunction compared to posterior and apical 
compartments with significant P value(p=0.018) [76]. In our study women with anterior 
compartment prolapse had more voiding dysfunction with the odds ratio of 2.22 (95% 
CI=0.13-37.55). However the p value 0.537 was not significant . A possible explanation for 
this finding may be that the prolapse of the anterior wall compartment produces pressure 
more directly on the urethra through a buttressing effect [76]. 
 
Stage of prolapse with defecatory dysfunction 
The cross sectional study done in Philadelphia, USA showed in their study  18% of 
stage II POP, 78% of stage III and 4% of stage IV POP, had defecatory dysfunction  [77]. In 
our study the overall prevalence of defecatory dysfunction was 60%.  In stage II, stage III 
and stage IV prolapse the presence of defecatory dysfunction was reported in 60% (n=3), 
58% (n=28),   71%(n=5)   respectively.   The P value 0.790 was not significant due to small 
numbers in stage IV POP. 
Compartment of prolapse with defecatory dysfunction 
 Ellerman et. al. had found a significant correlation between  posterior compartment 
prolapse and defecatory dysfunction[77]. Emily et. al. reported obstructive bowel symptoms 
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which significantly correlated with the presence of posterior  vaginal wall prolapse (OR 3.46; 
95% CI 1.69-7.01(p value= 0.001) [54]. Similarly, in our study women with posterior 
compartment defect have more defecatory dysfunction with the odds ratio of 2.49 (95% CI = 
0.773-7.993). A possible explanation for this finding  may be that the prolapse of the 
posterior wall compartment  produce an  anatomic redundancy of the  rectum in to the vagina 
(rectocele) or perineum (perineocele) resulting in more defecatory dysfunction. Posterior 
compartment defect leads to splinting and sense of incomplete evacuation[77]. 
Stage of prolapse with LUTS using IPSS 
The lower urinary tract disorders are common with pelvic organ prolapse due to loss 
of vaginal support. The International prostate symptom score was validated in 
postmenopausal women for evaluating lower urinary tract symptoms [65]. A study done by 
Obinata et. al. showed the severity of IPSS total scores significantly correlated with 
preoperative POP-Q stage and the total of 37% of stage 4 showed ≥ 20 IPSS [78]. In our 
study a total of 80% (n=4) of   stage II, 63% (n=30)of stage III and 71.4% (n=5)of stage IV 
POP had a IPSS score of  ≥20  which indicate severe LUTS.  The P value 0.475  not 
significant . 
Stage of prolapse with QOL using IPSS 
Advanced POP adversely affects QOL in women. Therefore, the treatment for POP is 
not just based on restoration of anatomy but aimed at improvement in the patient quality of 
life [58]. Various studies in the literature supports that the advanced stage of prolapse have 
negative impact on QOL [61-62]. In contrast, our study showed that 87.5% (n=42) of women  
in stage III POP  had unsatisfactory quality of life compared to 71% (n=5) in stage IV and 
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60% (n=3) in stage II POP. The P value was not significant (p=0.248)due to small numbers 
in stage IV POP. 
Stage of prolapse with pre & post-operative Q max and PVR 
Studies have reported a  decrease in urine flow rate and increase in PVR in women 
with high stage of POP. A study by Romanzi et al. showed 72% of women with advanced 
prolapse had low mean and Q max compared to 6% in stage I or II prolapse [46]. In our study 
it was noticed 40% (n=2) of stage II POP and 71% (n=5) stage IV had pre-operative Qmax 
<15 ml/sec, which was completely resolved after vaginal hysterectomy with pelvic floor 
repair. In stage III 42% (n=20) had pre-op Q max <15ml/sec, in that 98% (n=19) which 
resolved post operatively. 
A study by Romanzi et al. reported 30% of women with stage 3 or 4 prolapse have 
elevated post void residuals. Similarly in our study 50% (n=24) in stage III and 71% (n=5) in 
stage IV POP had elevated   pre-operative PVR which resolved post operatively in 96% 
(n=22) in stage III and 86% (n=4) in stage IV POP respectively.  
Correlation of pre and post-operative voiding dysfunction 
Nguyen et. al. studied the  resolution of motor urge incontinence after surgical repair 
of pelvic organ prolapse, and reported the detrusor instability resolved after vaginal 
reconstructive surgery in 63% [79]. In our study a total of 68% (n=41) of women  had pre-
operative voiding dysfunction, of which 93% (n= 38 )of women had resolution of voiding 
dysfunction  after vaginal hysterectomy with pelvic floor repair.  The P value is highly 
significant (p value <0.000). As all of the voiding symptoms and PVR and Q max were 
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significantly improved, after surgery voiding difficulty might be relieved by a re-supported 
pelvic floor [79].  
POP-Q points with voiding and defecatory dysfunction 
Studies showed that POP- Q points on the anterior vaginal wall correlate with voiding 
dysfunction and posterior points with defecatory dysfunction [76,46]. A study done by 
Jiyunchae et al. showed   POP-Q points Aa and Ba were significantly longer in women with 
voiding dysfunction [76]. In contrast to the above, the present study showed that the POP-Q 
points Aa and Ba did not correlate with voiding dysfunction.   P values (P=0.370&P=0.290) 
not significant. 
 Collins et al. studied the correlation of POP-Q posterior compartment measures with 
defecatory dysfunction and found the POP-Q  Bp point, but not perineal body measurement 
correlated with defecatory dysfunction [80]. Similarly, in our study the posterior 
compartment POP-Q points Point Ap and Point Bp   were significantly longer in women with 
defecatory dysfunction (P = of 0.02 and P =0.04). A possible explanation may be attributed 
to chronic constipation and rectocele in post-menopausal women which leads to weakness of 
the pelvic floor and recto vaginal septum causing more defecatory dysfunction [48-50]. 
Voiding and defecatory dysfunction is not life threatening, but has a detrimental 
effect on quality of life and adverse effect on psychological and social activity. Awareness 
about the symptoms of Voiding and defecatory dysfunction should be emphasized. Adequate 
pre-operative counseling of patients planned for pelvic reconstructive surgery is essential. 
Management of POP aims at improving the quality of life.  
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Conclusion  
This study has shown that 
1. The overall   prevalence of voiding dysfunction in this study was 68% and the defecatory 
dysfunction was 60%. 
2. The stage of the prolapse correlates with voiding dysfunction,  ( P value 0.050 was 
significant).  
3. Women with anterior compartment prolapse had more voiding dysfunction with the odds 
ratio of 2.22(95% CI=0.13-37.55). (P value 0.537 was not significant).  
4 .The stage of prolapse did not correlate with Defecatory dysfunction,  ( P value 0.790 was 
not significant). 
5 .Women with posterior compartment defect had more defecatory dysfunction with the odds 
ratio of 2.49(95% CI=0.773-7.993),  ( P value 0.145was not significant). 
6. Stage of POP did not correlate with severity of LUTS, (P value 0.475 was not significant). 
7. Stage of prolapse did not correlate with   QOL , ( P value 0.248 was not significant). 
8. Preoperative voiding dysfunction   resolved post operatively in 93% .( P value <0.000 was 
highly significant). 
9. The POP-Q Point Ap and Point Bp   were significantly longer in women with defecatory 
dysfunction  (P=  0.02 and P=0.04). 
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Annexure -1 
PROFORMA 
  
1.Name: 
2.Hospital Number:  
 
3. Age in years :   
 
4. Marital status:             1) Married 
                                            2) Unmarried 
 
 
5. Occupation:                 1) Not working    
                                           2) Manual labourer 
                                          3) Clerical  
                                          4) Professional 
 
 
6. Education:                  1) Nil   
                                        2) Schooling   
                                        3) Graduate  
                                       4) Postgraduate 
 
 
7. Socioeconomic status:     1) Class  I    
                                                 2) class II   
                                                 3) Class III 
 
 
8. Menopause status:                    1) Premenopausal  
                                                               2) Postmenopausal 
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9. Parity :                                               1) Nulliparous  
    2) Parous  
                                                               3) Multiparous 
 
 
10. Age at first child birth:                  1) <20 years 
                                                                 2) 20 to 30 years 
                                                                 3) >30 years 
 
 
11. Delivery :  
i. Vaginal delivery           1           2         3           4              5 
ii. Instrumental delivery    1           2         3           4              5         
iii. Caesarean delivery  : In labour                                                                      
   Not in labour                                          
 
 
12. History of prolonged labour:   1) yes 
       2) No 
 
 
13. Interval between delivery :  1)  <1 year    
      2) 1-2 years   
      3) >2years 
 
 
14. Resumption of work after delivery:  
      1)  <3 months   
      2) 3-6 months  
      3) >6 months 
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15. Place of delivery:    1) Home 
      2) Hospital 
 
 
16. Previous  
   Abdominal surgery :   1) Yes 
        2) No 
 
   Pelvic floor surgery :   1) Yes 
        2) No 
 
   Hernia repair:    1) Yes 
        2) No 
 
17. BMI:      
 
18.  Comorbidities:  
   Diabetes mellitus :   1) Yes 
        2) No 
 
   Chronic cough:   1) Yes 
        2) No 
 
   Hypertension:    1) Yes 
        2) No 
19. Duration of prolapse: 
   
 20. symptoms  
 Bulge symptoms    1) Yes 
       0) No 
 
 Sexual symptoms    1) yes 
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       2) No 
21. Lower Urinary Tract Symptoms: International Prostate Symptom Score (IPSS) 
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Incomplete emptying 
Over the past month, how often have you had a 
sensation of not emptying your bladder completely 
after you finish urinating? 
0 1 2 3 4 5 
 
Frequency 
Over the past month, how often have you had to 
urinate again less than two hours after you finished 
urinating? 
0 1 2 3 4 5 
 
Intermittency 
Over the past month, how often have you found 
you stopped and started again several times when 
you urinated? 
0 1 2 3 4 5 
 
Urgency 
Over the last month, how difficult have you found 
it to postpone urination? 
0 1 2 3 4 5 
 
Weak stream 
Over the past month, how often have you had a 
weak urinary stream? 
0 1 2 3 4 5 
 
Straining 
Over the past month, how often have you had to 
push or strain to begin urination? 
0 1 2 3 4 5 
 
Nocturia 
Over the past month, many times did you most 
typically get up to urinate from the time you went to 
bed until the time you got up in the morning? 
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Total IPSS score 
       
 
1.1.8. Quality of life due to urinary symptoms 
 
 
 D
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If you were to spend the rest of your life with your 
urinary condition the way it is now, how would you 
feel about that? 
0 1 2 3 4 5 6 
Total score: 0-7 Mildly symptomatic; 8-19 moderately symptomatic; 20-35 severely symptomatic. 
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(b) Colorectal Anal Distress Inventory 8 (CRADI-8) 
 
 
(b) Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6) 
Do you experience, and, if so, how much are 
you bothered by …..  
No Not at all SomeWhat Moderately Quite a Bit 
Feel you strain too hard to have bowel 
movement?  
     
Feel you have not completely emptied your 
bowel at the end of a bowel 
     
Feel you have lose stool beyond your 
control if your stool is well formed? 
     
Usually lose stool beyond your control if 
your stool is loose? 
     
Usually lose gas from the rectum beyond 
your control? 
     
Do you usually have pain when you pass 
your stool? 
     
Experience a strong sense of urgency and 
have to rush to the bathroom to have a 
bowel movement? 
     
Does part of your bowel ever pass through 
the rectum and bulge outside during or after 
a bowel movement? 
     
Do you experience, and, if so, how much are 
you bothered by …..  
No Not at all SomeWhat Moderately Quite a Bit 
Usually experience pressure in the lower 
abdomen? 
     
Usually experience heaviness or dullness in 
the pelvic area? 
     
Usually have a bulge or something falling 
out that you can see or feel in your vaginal 
area? 
     
Ever have to push on the vagina or around 
the rectum to have or complete a bowel 
movement? 
     
Usually experience a feeling of incomplete 
bladder emptying? 
     
Ever have to push up on the bulge in the 
vaginal area with your fingers to start or 
complete urination? 
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22. Pelvic Organ Prolapse Quantitative Examination Measurements 
1.  Aa  
2.  Ba  
3.  C  
4.  Ap  
5.  Bp  
6.  D  
7.  GH  
8.  PB  
9.  TVL  
Stages of Prolapse 
10.  Stage 0  
11.  Stage 1  
12.  Stage 2  
13.  Stage 3  
14.  Stage 4  
Compartment of Prolapse 
15.  Anterior 1. Yes      2. No 
16.  Posterior 1. Yes      2. No 
17.  Apical 1. Yes      2. No 
23. Investigation 
1.  Voiding Diary 1. Significant      0. Not Significant 
2.  Urine Micro Normal/Abnormal 
3.  Urine Culture 
Sensitivity 
1. Growth      0. No Growth 
4.  Post void 
Residual Volume 
in ml 
 ……. ml  
 1. Significant       0. Not Significant 
      Flow 
5.  Flow rate  
6.  Voided Volume  
7.  Maximum flow rate  
8.  Voiding time  
9.  Flow time  
10.  Average flow rate  
11.  Time to Maximum 
flow 
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24.Type of anaesthesia:  
   1)GA     2)SA  
   3) Epidural    4)LMA  
 
 Duration of surgery: 
 Post operative retention of urine:  1)Yes  
  2)No 
 Duration of catheterisation: 
 
 Duration of surgery 
 
 
 
 Post operative retention of urine:  1)Yes  
  2)No 
 Duration of catheterisation: 
 
 6TH Post Operative Flow &  PVR 
 
25. Uroflow 
 
  
1. Flow rate 
 
2. Voided Volume 
 
3. Maximum flow rate 
 
4. Voiding time 
 
5. Flow time 
 
6. Average flow rate 
 
7. Time to Maximum flow 
id age occ edu ses meno dom mart parity afcb
1 53 1 2 3 2 1 3 1
2 68 1 1 3 2 240 1 3 2
3 71 1 2 2 2 340 1 3 2
4 62 1 4 2 2 222 1 3 1
5 59 2 1 3 2 120 1 2 1
6 48 2 1 3 2 36 1 3 1
7 54 1 3 3 2 180 1 3 1
8 57 2 1 3 2 60 1 3 1
9 62 1 1 1 2 240 1 3 1
10 55 2 2 3 2 96 1 3 1
11 50 1 2 3 2 60 1 3 1
12 68 1 2 3 2 252 2
13 65 2 1 3 2 120 1 1
14 66 1 2 1 2 192 1 3 1
15 76 3 3 3 2 240 1 3 1
16 53 1 2 2 2 70 1 3 1
17 61 2 1 3 2 240 1 3 1
18 60 2 1 3 2 120 1 3 1
19 63 1 1 3 2 180 1 3 1
20 48 4 4 3 2 120 1 3 1
21 54 2 1 3 2 108 1 3 1
22 41 1 2 3 2 48 1 3 1
23 52 2 1 3 2 72 1 3 1
24 78 1 2 2 2 326 1 3 1
25 52 1 2 2 2 48 1 3 1
26 56 1 2 2 2 72 1 3 1
27 75 1 2 3 2 360 1 3 1
28 40 1 2 2 2 60 1 3 1
29 57 1 1 3 2 60 1 3 1
30 55 1 1 2 2 72 1 3 1
31 50 2 2 3 2 24 1 3 1
32 75 1 1 3 2 360 1 3 1
33 65 4 4 1 2 264 1 3 2
34 60 1 2 2 2 12 1 3 1
35 51 2 1 3 2 120 1 3 1
36 66 1 2 3 2 192 1 3 1
37 64 4 4 1 2 84 1 3 3
38 50 1 1 3 2 24 1 2 1
39 52 1 2 2 2 120 1 3 1
40 61 1 2 3 2 240 1 3 1
41 67 1 2 3 2 180 1 3 1
42 48 1 1 3 2 72 1 3 1
43 52 1 2 3 2 72 1 3 1
44 53 1 2 3 2 120 1 3 1
45 55 1 2 2 2 132 1 3 1
46 67 3 2 2 2 180 1 3 1
47 62 1 3 1 2 360 1 3 2
48 72 3 3 2 2 240 2
49 52 1 3 2 2 30 1 3 1
50 46 1 2 2 2 36 1 3 1
51 58 1 1 2 2 72 1 3 1
52 56 2 2 3 2 36 1 3 1
53 65 1 1 3 2 120 1 3 1
54 58 1 1 3 2 96 1 3 1
55 53 3 3 1 2 24 1 3 2
56 65 2 1 2 2 120 1 3 1
57 49 1 1 3 2 12 1 3 1
58 60 2 1 3 2 120 1 3 1
59 57 1 2 2 2 120 1 3 1
60 56 3 3 3 2 72 1 3 2
nvd ovd cs hopl idi row pod abd pf herniasx
4 0 0 1 1 1 1 0 0 0
2 0 1 1 1 1 2 1 0 0
5 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 2 0 0 0
2 0 0 0 3 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 1 1 0 0
4 0 0 1 1 1 1 0 0 0
7 0 0 1 1 1 1 0 0 0
5 0 0 1 1 1 1 0 0 0
3 0 0 1 1 2 2 0 0 0
0 0 0
0 0 0
4 0 0 1 1 1 1 0 0 0
5 0 0 1 1 1 2 0 0 0
3 0 0 1 1 1 2 0 0 0
4 0 0 1 1 1 1 0 0 0
8 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
2 0 0 1 1 1 2 0 0 0
3 0 0 1 1 1 2 0 0 0
5 0 0 0 1 1 1 0 0 0
4 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 1 0 0 0
2 0 0 0 2 1 2 0 0 0
3 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 1 0 0 0
0 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
3 0 0 0 2 1 1 0 0 0
4 0 0 1 1 1 1 0 0 0
3 3 0 1 2 1 2 0 0 0
4 0 0 1 1 1 2 0 0 0
6 0 0 1 1 1 1 0 0 0
2 0 0 1 2 1 1 0 0 0
2 1 0 0 2 1 2 0 0 0
3 0 0 1 1 1 1 0 0 0
3 0 0 1 2 1 1 0 0 0
3 0 0 1 2 1 2 0 0 0
5 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
1 0 1 1 2 1 2 1 0 0
2 0 0 1 1 1 1 0 0 0
2 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 1 0 0 0
0 0 2 0 3 2 2 1 0 0
0 0 0
3 0 0 1 1 1 2 0 0 0
3 0 0 1 1 1 1 1 0 0
4 0 0 1 1 1 1 0 0 0
3 0 0 1 1 1 1 0 0 0
5 0 0 1 1 1 1 0 0 0
2 0 0 1 1 1 1 0 0 0
2 0 0 0 2 2 2 0 0 0
5 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 2 0 0 0
3 0 0 1 1 1 1 0 0 0
4 0 0 1 1 1 2 0 0 0
3 0 0 0 2 2 2 0 0 0
bmi dm ht cc duration bulge sexual ipss severity qol
27 0 0 0 6 1 0 21 3 3
26 0 0 0 18 1 1 12 2 2
20 0 1 0 72 1 1 22 3 3
21 0 0 0 60 1 1 10 2 3
22 0 0 0 90 0 0 26 3 3
22.4 0 0 0 12 1 0 9 2 2
20.5 0 0 0 180 1 0 22 3 3
24 0 0 0 5 0 0 21 3 3
18.17 1 0 0 12 1 1 23 3 4
30 1 0 1 8 1 1 23 3 4
22 0 0 0 252 1 0 20 3 4
25.3 0 0 0 48 1 0 25 3 5
30 0 1 0 24 0 0 22 3 4
30 0 1 1 96 1 0 18 2 3
31 1 0 0 36 1 0 15 2 3
31 1 0 0 6 1 0 28 3 4
20.6 0 0 0 24 1 1 24 3 4
15 0 0 0 6 1 0 26 3 5
30 1 0 0 36 1 0 14 3 4
32 1 1 0 48 1 0 23 3 4
23.5 0 0 0 46 1 0 15 2 3
24.5 0 0 0 192 1 0 28 3 2
22 0 1 0 72 1 0 15 2 3
22 0 0 0 120 1 0 21 3 4
32.5 1 0 0 48 1 0 26 3 5
31 0 0 0 72 1 0 20 3 4
18.1 0 0 0 120 1 0 7 1 1
21.1 1 0 0 7 1 1 22 3 4
30 0 1 0 6 1 0 27 3 3
21.5 0 0 0 24 1 0 16 2 3
32 1 1 0 12 1 0 12 2 2
21.6 0 0 0 12 1 0 20 3 3
22.5 1 0 0 7 1 0 21 3 3
22 1 0 0 12 1 1 14 2 3
18 0 0 0 60 1 1 22 3 3
24.5 1 0 0 420 0 0 14 2 2
30 0 0 0 312 1 0 16 2 4
24 0 0 0 12 1 0 15 2 2
23.6 0 0 0 84 1 0 13 2 2
30 0 0 0 120 1 1 23 3 3
23.6 0 0 0 120 1 1 7 1 3
21.6 0 0 0 72 1 0 21 3 4
27.7 0 0 0 12 1 0 13 2 2
26.4 0 1 0 6 1 0 22 3 3
21.8 0 1 0 132 1 1 12 2 2
32 1 1 0 24 1 0 21 3 3
35 1 0 1 70 1 0 25 3 4
31 1 1 0 6 1 0 21 3 3
29 0 0 0 24 1 0 17 3 3
21.1 0 0 0 12 1 1 12 2 3
34.7 0 1 0 36 1 0 23 3 3
19.2 0 0 0 12 1 0 15 2 3
20.2 0 0 0 10 1 0 28 3 4
26.1 0 0 0 2 1 0 25 3 5
24 0 0 0 36 1 0 28 3 4
26 0 0 0 12 1 0 13 2 3
31 1 0 0 72 1 0 21 3 4
30 0 1 0 24 1 0 22 3 3
32.8 1 1 0 12 1 0 21 3 4
23.3 1 1 0 24 1 0 28 3 3
cradi8 cradiq1 cradiq2 cradiq3 cradiq4 cradiq5 cradiq6 cradiq7 cradiq8 popdi6
10 1 1 0 0 1 0 0 0 9
12 1 1 0 1 1 0 0 0 7
8 1 0 0 0 1 0 0 0 5
0 0 0 0 0 0 0 0 0 3
11 1 1 0 0 1 0 0 0 13
6 0 0 0 0 1 0 0 0 2
16 1 1 0 0 0 1 0 0 6
18 1 1 0 0 1 1 0 0 6
8 1 0 0 0 0 1 0 0 2
13 1 1 0 0 0 1 0 0 6
8 1 1 0 0 0 0 0 0 12
8 0 0 0 0 0 0 0 0 12
14 1 1 0 0 1 1 0 0 6
12 1 1 0 0 0 0 0 0 12
14 1 1 0 0 0 0 0 0 6
18 1 1 0 0 0 1 0 0 9
8 1 0 0 0 1 0 0 0 8
22 1 1 0 0 1 1 0 0 20
9 1 0 0 0 0 0 0 0 18
8 1 1 0 0 0 0 0 0 6
8 0 0 0 0 0 0 0 0 6
8 1 1 0 0 1 1 0 0 6
8 1 0 0 0 0 0 0 0 10
14 1 1 0 0 1 0 0 0 6
14 1 1 0 0 1 0 0 0 20
8 1 0 0 0 0 0 0 0 9
8 1 0 0 0 0 0 0 0 8
8 1 0 0 0 0 0 0 0 6
12 1 1 0 0 0 0 0 0 12
10 1 1 0 0 0 0 0 0 9
8 0 0 0 0 0 0 0 0 8
8 1 1 0 0 1 0 0 0 9
8 1 0 0 0 0 0 0 0 6
8 0 0 0 0 0 0 0 0 6
8 1 1 0 0 0 0 0 0 6
8 1 1 0 0 1 0 0 0 6
8 1 0 0 0 0 0 0 0 7
7 1 0 0 0 0 0 0 0 6
8 0 0 0 0 0 0 0 0 6
9 1 1 0 0 0 0 0 0 0
8 0 0 0 0 1 0 0 0 6
9 1 0 0 0 0 0 0 0 10
24 1 1 0 0 1 1 0 0 20
12 1 1 0 0 1 1 0 0 16
9 1 1 0 0 1 0 0 0 9
12 1 1 0 0 0 1 0 0 12
21 1 1 0 0 0 1 0 0 18
9 0 0 0 0 0 0 0 0 8
8 0 0 0 0 0 0 0 0 6
21 1 1 0 0 0 0 0 0 9
12 1 1 0 0 0 0 0 0 9
9 1 0 0 0 0 0 0 0 3
21 1 1 0 0 1 1 0 0 12
14 1 1 0 0 1 0 0 0 9
16 1 1 0 0 1 1 0 0 15
8 1 0 0 0 0 0 0 0 6
15 1 1 1 0 0 1 1 0 3
8 0 0 0 0 0 0 1 0 3
8 0 1 0 0 0 0 0 0 6
8 1 0 0 0 0 0 0 0 6
aa ba c ap bp d gh pb tvl stage
2 4 5 -2 -2 0 5 2 7 4
2 4 5 -3 -1 2 4.5 2.5 8 4
3 3 4 -2 -2 3 5.5 2 7 4
-3 -3 4 -3 -3 -7 4.5 2.5 8 4
2 3 4 -2 -2 -4 4 2 7 4
1 4 -2 -1 -2 -4 5 2.5 8 4
3 5 4 3 5 4.5 2.5 8 4
3 4 6 1 3 4 5 1 6 5
1 4 1 -1 -1 -1 4.5 1.5 8 3
3 4 6 1 0 1 6 2.5 8 4
3 6 8 5 6 7 5 1.5 8 5
2 5 6 -3 -1 5 5.5 2 8 4
3 3 4 3 2 3 3.5 2 5 4
3 4 6 1 2 2 5 1.5 8 4
3 4 5 0 1 2 5 1.5 8 4
3 5 7 1 2 -3 5 2.5 7 5
2 3 4 -3 -3 -1 4.5 2.5 8 4
3 4 5 3 3 6 4.5 2.5 7 4
3 5 6 2 3 5 5 1.5 8 4
3 4 2 -2 -2 -2 4.5 2 7 4
3 4 -2 -2 -2 -3 4 2 5 4
-2 -1 -2 -1 -1 -3 5 3 7 3
3 3 4 0 0 -2 4 2 7 4
3 4 4 -1 -1 -2 5.5 1 7 4
2 -1 -3 -2 0 -5 4.5 2 8 4
3 3 4 2 2 0 4 2 8 4
3 5 7 0 4 5 4 2.5 7 5
3 4 5 -2 -2 0 5.5 2.5 8 4
2 3 5 1 2 2 4 2 8 4
3 3 5 1 2 3 5 2 8 4
0 1 -2 -3 -3 -3 5 2.5 6 3
1 3 4 -1 1 2 4.5 1 6 4
3 4 5 1 2 2 4 2 8 4
2 3 4 -3 -2 -1 4.5 1.5 5 4
3 4 5 -1 -1 -2 5 2 7 4
3 5 7 3 6 6 5 2 7 5
1 2 3 -3 -3 -2 4.5 2 9 4
1 4 3 -2 -3 2 5 2 7 4
3 4 5 -2 2 0 6 2.5 8 4
1 2 4 -1 0 2 4.5 2.5 9 4
3 4 3 0 0 0 4 2.5 7 4
3 5 3 -1 1 0 5 2 7 4
3 5 7 1 3 5 7 1.5 9 4
3 4 6 -3 0 1 4 2 7 4
1 2 -1 -2 -3 -3 4.5 2 8 4
0 3 4 -1 -1 -1 5 2 8 4
3 4 5 2 2 3 5 2 8 4
-3 1 2 -3 -3 -4 4.5 2.5 8 4
0 0 -4 -3 -3 -5 5 1.5 7 3
-3 -3 -4 2 3 5 2 5 4
2 3 4 -1 0 1 4.5 2.5 9 4
2 3 -2 -2 -3 -3 5 1.2 7 4
2 3 4 0 2 -1 4 2.5 7 4
-2 -1 0 -3 -3 -5 4 2 7 3
3 4 5 7 8 6 5 2.5 7 5
0 2 3 -1 0 2 4 2 7 4
3 5 6 -3 3 5 5.5 2 8 4
3 6 7 2 4 -1 4.5 1.5 9 4
3 5 6 -3 -1 -1 5 1.5 8 4
0 4 6 -2 1 4 5 1.5 7 5
ant pos api vd urimicro urinecs pvr flow volume max
1 1 1 0 1 0 102 145 5.1
1 1 1 1 1 0 25 12.4 384 38.5
1 1 1 1 1 0 208 25 438 5.8
0 0 1 0 1 0 75 8 314 10.1
1 0 1 1 1 0 102 22 400 24
1 0 0 0 1 0 100 24 340 26
1 1 1 0 1 110 24 383 22.1
1 1 1 1 1 0 108 24 400 24
1 0 1 0 1 0 85 22 200 17
1 1 1 0 1 0 110 28 560 30
1 1 1 0 0 0 150 23 252 23
1 1 1 1 0 0 105 28 372 24
1 1 1 0 1 0 75 25 300 11.9
1 1 1 1 1 0 102 26 600 28
1 1 1 1 1 0 110 9.6 230 9.6
1 1 1 0 1 0 50 7 523 7.7
1 0 1 0 1 0 28 20.5 416 27.8
1 1 1 0 1 0 30 21.4 165 14
1 1 1 1 0 0 45 5.7 334 18
1 0 1 0 1 0 35 19.9 297 20
1 0 0 0 1 0 40 12 204 10.7
1 1 0 0 1 105 12 220 15
1 1 1 0 1 0 0 25 200 20
1 1 1 0 1 0 90 14 500 16.6
1 0 0 0 1 0 108 18 320 18
1 1 1 0 1 50 25 286 26.7
1 1 1 0 1 0 80 10 250 10
1 1 1 0 0 1 20 21 253 17
1 1 1 0 1 50 18 430 24
1 1 1 0 1 0 120 500 25
1 0 0 0 1 50 300 14.5
1 1 1 0 1 55 230 15
1 1 1 0 0 0 30 160 7
1 1 1 1 0 1 0 614 17.8
1 1 1 1 0 0 125 350 30
1 1 1 0 1 0 105 191 10.5
1 0 1 0 1 0 110 200 7
1 1 1 0 1 0 80 300 20
1 1 1 1 0 1 108 160 19.6
1 1 1 0 1 80 400 18
1 0 1 0 1 13 392 22
1 1 1 0 1 75 508 28.6
1 1 1 0 1 0 105 145 6.5
1 1 1 0 1 0 110 176 9.2
1 0 0 1 1 0 43 616 22
1 1 1 1 1 0 120 246 4.9
1 1 1 1 1 102 180 13
1 0 1 1 1 0 106 14 200 14
1 0 0 1 1 0 90 250 15
0 1 0 0 1 0 70 593 29
1 1 1 0 1 102 300 16
1 0 1 0 1 0 102 180 14
1 1 1 1 1 0 110 200 10.3
1 0 1 0 1 0 55 250 13
1 1 1 1 1 0 110 200 13
1 1 1 0 1 0 100 200 12
1 1 1 1 0 1 120 190 10
1 1 1 0 1 0 90 250 14
1 1 1 1 0 0 86 180 12
1 1 1 1 0 1 115 200 11
void flow1 aveflow timemaxflanaesthesidos retension doc postflow postopvol
24 24 4.1 10.04 2 90 0 2 200
29 29 12.4 3 2 60 0 2 25 193
38 37 5.4 22.3 2 60 0 2 78 500
32 22 8.6 17.6 1 60 0 1 500
34 34 20 10 2 60 0 2 500
28 28 14 8 2 60 0 2 23 560
35.2 35.2 10.8 8.8 2 75 0 3 24 540
36 36 20 10 2 120 1 21 20 500
30.4 30.4 15 4.8 2 60 1 21 500
45 45 16 4 2 60 0 2 26 300
29 29 20 8 2 60 0 2 26 506
34 34 12 4 2 75 0 2 29 360
40 40 23 8 2 60 0 2 35 600
40 40 14 7 2 65 0 2 27 400
46.8 46.8 4.9 20.8 2 75 0 2 10 250
70 70 3.7 4 2 60 0 2 15 256
28.5 28.5 14.4 8.3 2 90 0 2 22.5 315
22.8 22.8 7.2 10.4 2 75 0 2 18 200
69.3 69.3 5.7 10 2 70 0 2 22 280
56 56 11 5 2 60 0 2 33 566
35.6 35.6 5.6 16.8 2 60 0 2 8 296
28 28 11 10 2 90 0 2 13 290
30 30 15 5 2 60 0 3 22 600
34 34 8.2 5 2 75 0 2 22 214
22 22 12 4 2 60 0 2 22 235
19.2 19.2 14.8 8.4 2 75 0 2 24 300
25 25 9 10 2 70 0 2 22 350
20 20 6.7 11.7 2 65 0 2 20 200
30 30 15 7 2 80 0 2 22 450
35 35 15 15 2 60 0 2 22 450
42 42 16 15 2 75 0 2 250
20 20 8 4 2 70 0 2 280
53 53 6 25 1 90 0 2 200
64 64 8 13.6 2 90 1 5 350
52 52 18 15 2 90 0 2 400
64.8 64.8 8 5.2 2 80 0 3 250
50 50 4 2 2 90 0 3 500
30 30 7 10 2 90 0 2 513
28 28 8 6 1 80 0 2 400
32 32 9 20 2 60 0 2 600
30.8 30.8 12.7 8.8 2 60 0 2 509
46 46 14 8 2 75 0 2 264
88 88 33 2 75 0 2 244
29.2 29.2 6 7.2 2 90 0 2 280
30.4 30.4 20.2 30.4 2 70 0 2 503
35.6 35.6 2 6 1 90 0 2 320
30 30 7 5 2 90 0 3 250
35 35 7 5 2 80 0 3 400
25 25 8 7 2 90 0 2 300
33 33 5 2 60 0 2 500
25 25 5 2 80 0 2 350
20 20 5 2 65 0 2 350
35 35 4 2 90 0 3 400
26 26 6 2 80 0 2 350
36 36 8 5 2 120 0 2 450
30 30 6 5 2 120 0 4 400
40 40 4 2 75 0 2 560
30 30 7 6 2 60 0 2 400
25 25 6 2 60 0 2 380
30 30 6 5 2 90 1 5 600
popmax pop poflow poaveflowpotimemaxpop1
20 23 23 9 5 18
16.4 25 25 3.6 7.2 100
22 36 36 21 20 100
15 35 35 9 4 57
26 36 36 12 6 80
26 30 30 12 12 50
25 36 36 20 9 10
18 40 40 16 14 200
20 30 30 16 6 100
25 32 32 13 5 30
22 40 40 24 22 60
26 22 22 13 7 50
16 16 16 14 20 27
25 30 30 13 8 55
20 32 32 14 7 45
23.4 19.2 19.2 13.3 8 40
25.9 34.8 34.8 9 4.4 25
20 35 35 14 7 10
23.1 28 28 5.6 2.4 43
34.7 50.4 50.4 15 11.2 20
9 49.2 49.2 4.9 24 48
16 32 32 8 5 20
30.9 57.6 57.6 16 11 15
24.7 18 18 11.9 8.4 75
26.2 16 16 14.7 8 60
26 22 22 15 10 60
18 30 30 15 5 78
17 23 23 6.7 11 43
25 35 35 15 8 60
22 40 40 16 15 50
15 30 30 14 14 30
17.6 18.8 18.8 9.7 8 25
15 40 40 10 26 25
19 35 35 8 6 60
20 25 25 10 10 50
16 52 52 7 5 20
25 35 35 10 5 20
22.9 51.6 51.6 9.9 11.2 90
24 34 34 10 5 90
25 35 35 10 6 25
26.9 36.8 36.8 13.8 12 25
25.4 30.4 30.4 8.7 7.6 15
22 23 23 10 5 25
15.6 32 32 7 8 25
22.9 40 40 14 5 64
25.8 40 40 15 8 65
16 26 26 8 4 60
22 36 36 10 8 50
20 25 25 10 7 25
20 25 25 10 6 50
20 26 26 6 25
18 30 30 5 20
25 30 30 12 8 24
20 25 25 5 25
25 30 30 5 40
25 36 36 10 5 20
28 30 30 4 35
22 35 35 10 4 25
21 28 28 10 8 20
25 40 40 12 4 50
